inpharmd-asset1000true/General_Adult_Medical_Order_Set_S20251205-5-ub6sdr.pdf2025-12-05T12:33:48.000Z"5b96f418ce72d4b91998b440d565d3e0"CRC64NVMEFULL_OBJECT995617STANDARD/General_Adult_Medical_Order_Set_S20251208-7-tcppfc.pdf2025-12-08T05:59:09.000Z"5b96f418ce72d4b91998b440d565d3e0"CRC64NVMEFULL_OBJECT995617STANDARD/Inpharmd_Response20241216-58816-56gsse.pdf2024-12-16T05:26:53.000Z"6e7baca26b026640dc5534ace4f5e608"199791STANDARD/Inpharmd_Response20241218-58816-gb8pn4.pdf2024-12-18T14:30:53.000Z"303acebe0ac2561ef56417f4f7e55218"214357STANDARD/Inpharmd_Response20241219-58816-cecl72.pdf2024-12-19T06:08:12.000Z"0324e2cf62f49909dede89ec4de9d4c2"169689STANDARD/Inpharmd_Response20241219-58816-l1g0xj.pdf2024-12-19T06:34:39.000Z"7699a110419928e6e092bcb220541591"169689STANDARD/Inpharmd_Response20241219-58816-luqy7m.pdf2024-12-19T06:42:27.000Z"a3def4f743aa8263c4276f5225a81848"169689STANDARD/Inpharmd_Response20241219-58816-rv4437.pdf2024-12-19T06:11:59.000Z"98b49f7cac20faf56a72eb72270fe04b"169689STANDARD/Inpharmd_Response20241219-58816-s55ek6.pdf2024-12-19T05:08:48.000Z"bfa49196cf2aad57dc2fdcdcd1416bc9"255869STANDARD/Inpharmd_Response20241219-58816-t7csww.pdf2024-12-19T07:00:29.000Z"fa0d23bbfc785d47c686ca25ce4b5275"169689STANDARD/Inpharmd_Response20241219-58816-y2g9w4.pdf2024-12-19T06:15:24.000Z"1fcf6a1ee0d6330cacb0bcc16ccd603e"169689STANDARD/Inpharmd_Response20241223-3302-bzqm6d.pdf2024-12-23T07:09:14.000Z"6a5d17f3b544d1b225dbdefa5ef777d1"176992STANDARD/Inpharmd_Response20241223-3302-dw6eye.pdf2024-12-23T07:13:59.000Z"9b94bdf47bcc004bc6c66ee0389eab35"166922STANDARD/Inpharmd_Response20241231-4647-h8928k.pdf2024-12-31T11:09:38.000Z"f4b9663a546e0456dcdd158a572d75bd"175975STANDARD/Inpharmd_Response20250131-51191-7haxqr.pdf2025-01-31T10:11:39.000Z"a8d29699e45aee698dd87bcb99fad98c"217996STANDARD/Inpharmd_Response20250131-51191-ra2l8z.pdf2025-01-31T10:13:35.000Z"3590e98d2ba77d3c4d4c3c6f9c2c5acf"204313STANDARD/Inpharmd_Response20250418-28672-8jdpjw.doc2025-04-18T09:31:49.000Z"d8e9a8a196b9e901c4d583ce49cb129a"CRC64NVMEFULL_OBJECT143682STANDARD/Inpharmd_Response20250624-24332-ahn58e.doc2025-06-24T07:18:46.000Z"3cd8fa401c36dd01e80ba6af3ad57436"CRC64NVMEFULL_OBJECT61854STANDARD/Inpharmd_Response20250624-24332-eiuzmb.doc2025-06-24T07:18:49.000Z"7aa6c479cdd3e504d3d1a596f1f91489"CRC64NVMEFULL_OBJECT61854STANDARD/Inpharmd_Response20250624-41098-l3t9ty.doc2025-06-24T13:47:31.000Z"ee012bcddb1aa5691b670344ec8eadd1"CRC64NVMEFULL_OBJECT62943STANDARD/Inpharmd_Response20250624-41098-rryvpf.doc2025-06-24T13:48:14.000Z"d4ac221f75f7dd59a526847c2326ed82"CRC64NVMEFULL_OBJECT42213STANDARD/Inpharmd_Response20250624-41098-ud23sx.doc2025-06-24T13:46:01.000Z"18ff5bc2e6275d6d330eec0e336c00b0"CRC64NVMEFULL_OBJECT61864STANDARD/Inpharmd_Response20250624-41098-yaon3t.doc2025-06-24T07:30:33.000Z"866720c57c295db214e921724ed2522c"CRC64NVMEFULL_OBJECT64528STANDARD/Inpharmd_Response20250704-76387-7brg8f.doc2025-07-04T12:50:19.000Z"0f11f4e97eb8e7f2665e7cf95099bfed"CRC64NVMEFULL_OBJECT140462STANDARD/Inpharmd_Response20250711-31188-ga9410.doc2025-07-11T06:02:26.000Z"5dc6fd5099ddbbae0113d690297bbbe7"CRC64NVMEFULL_OBJECT160096STANDARD/Inpharmd_Response20250723-35207-gv32l3.doc2025-07-24T02:07:47.000Z"20b3639ec9570339dbd2e279524b6d61"CRC64NVMEFULL_OBJECT114165STANDARD/Inpharmd_Response20250725-4838-xsekbl.doc2025-07-25T13:01:53.000Z"ae281eda553cc925161a02fc4b41129f"CRC64NVMEFULL_OBJECT113867STANDARD/Inpharmd_Response20250729-27829-jlvi6g.doc2025-07-30T00:36:50.000Z"4ea890ed9dc28b4d1f9b9f8559c15204"CRC64NVMEFULL_OBJECT114200STANDARD/Inpharmd_Response20250729-27829-n588jo.doc2025-07-30T00:25:46.000Z"a02b520cf220f09f6bb387d21f1bbeaf"CRC64NVMEFULL_OBJECT114809STANDARD/Inpharmd_Response20250729-27829-rvd6vh.doc2025-07-30T00:38:25.000Z"93092140aeda99ac7b3fd8bd506fe26b"CRC64NVMEFULL_OBJECT114211STANDARD/Inpharmd_Response20250729-27829-yq8g94.doc2025-07-30T00:32:17.000Z"3bfa6c0b79b2c794e099eaff9d8f4751"CRC64NVMEFULL_OBJECT114219STANDARD/Inpharmd_Response20250807-26270-k6t9nn.doc2025-08-07T06:48:17.000Z"4db1da7241fd9b7cdc2cc6c077746134"CRC64NVMEFULL_OBJECT139294STANDARD/Inpharmd_Response20250807-26270-kfiutd.doc2025-08-07T06:40:28.000Z"1b92a83d5d534204a17a5c8c20f7d589"CRC64NVMEFULL_OBJECT113337STANDARD/Inpharmd_Response20250807-36104-2enj8o.doc2025-08-07T07:01:28.000Z"0e30bbfd6b668158ce2e595cdd023158"CRC64NVMEFULL_OBJECT36596STANDARD/Inpharmd_Response20250807-36668-g4tr02.doc2025-08-07T08:39:33.000Z"afb44e963e8a1646886be818edeb5c8e"CRC64NVMEFULL_OBJECT113329STANDARD/Inpharmd_Response20250807-36668-ssef6p.doc2025-08-07T08:40:13.000Z"c2edd42883ca46af684271527898bee8"CRC64NVMEFULL_OBJECT113349STANDARD/Inpharmd_Response20250807-37496-t19box.doc2025-08-07T08:59:36.000Z"864c6de3715e2cd64186d2970b24d975"CRC64NVMEFULL_OBJECT113306STANDARD/Inpharmd_Response20250807-37768-x26wpn.doc2025-08-07T09:21:39.000Z"4fb606b5750546a3c8c8ffcd8d7e1045"CRC64NVMEFULL_OBJECT122405STANDARD/Inpharmd_Response20250807-37877-fm8ygr.doc2025-08-07T09:27:51.000Z"37ad18463b40e0e87eb29fe247a5b682"CRC64NVMEFULL_OBJECT157472STANDARD/Inpharmd_Response20250807-37877-kzxpwg.doc2025-08-07T09:28:57.000Z"051143af9d954ca4c64498b1e09f9df9"CRC64NVMEFULL_OBJECT122374STANDARD/Inpharmd_Response20250807-37956-8rai1a.doc2025-08-07T09:33:38.000Z"1ee0655b4688c80f489d2f22eb64d0dc"CRC64NVMEFULL_OBJECT122377STANDARD/Inpharmd_Response20250807-38026-6vcanh.doc2025-08-07T09:38:40.000Z"a9d17dd2e805cf693d4af45397185e00"CRC64NVMEFULL_OBJECT122371STANDARD/Inpharmd_Response20250807-38026-9gq36e.doc2025-08-07T09:43:03.000Z"cabf00db507dd53bc245b5d551685cb1"CRC64NVMEFULL_OBJECT122369STANDARD/Inpharmd_Response20250807-38026-y9j2wm.doc2025-08-07T09:39:51.000Z"f2f356db8038908cab8500a899ec3c52"CRC64NVMEFULL_OBJECT122359STANDARD/Inpharmd_Response20250807-38175-811t8i.doc2025-08-07T09:46:42.000Z"05cafea4aa9222526ffe2ee1e79ec612"CRC64NVMEFULL_OBJECT122369STANDARD/Inpharmd_Response20250807-38175-t03wi8.doc2025-08-07T09:46:57.000Z"d876dc07b8bb7b5a7b6501743537d30c"CRC64NVMEFULL_OBJECT122370STANDARD/Inpharmd_Response20250807-38262-8c969v.doc2025-08-07T09:52:38.000Z"8b371fa61adcbc4f2626cdad5d97f7d1"CRC64NVMEFULL_OBJECT122358STANDARD/Inpharmd_Response20250807-38262-9d9g4x.doc2025-08-07T09:50:40.000Z"684cde8ae45ed3d80ba9416e77ee9156"CRC64NVMEFULL_OBJECT122388STANDARD/Inpharmd_Response20250807-38262-dfube0.doc2025-08-07T10:00:43.000Z"9be0bbd1df9516907232ac92695907c6"CRC64NVMEFULL_OBJECT122358STANDARD/Inpharmd_Response20250807-38262-rnh1qn.doc2025-08-07T09:52:01.000Z"44c9de59312812412fe69acb02a5fdf8"CRC64NVMEFULL_OBJECT122380STANDARD/Inpharmd_Response20250807-38385-1ljo32.doc2025-08-07T10:13:35.000Z"298651051ea2c6f184a9758929058a6d"CRC64NVMEFULL_OBJECT113162STANDARD/Inpharmd_Response20250807-38385-202l1i.doc2025-08-07T13:30:49.000Z"4fe6c0cc0fe6a6c32035775fd650ee42"CRC64NVMEFULL_OBJECT122360STANDARD/Inpharmd_Response20250807-38385-28wgof.doc2025-08-07T12:50:07.000Z"2cd88f430b16c3418e4a538fc27ee892"CRC64NVMEFULL_OBJECT122380STANDARD/Inpharmd_Response20250807-38385-29ojh0.doc2025-08-07T13:06:53.000Z"7cb64fc5263ae6879d550919c15386c3"CRC64NVMEFULL_OBJECT122577STANDARD/Inpharmd_Response20250807-38385-2n3rxj.doc2025-08-07T10:35:50.000Z"bae67704b3a609e23ea81825ac695a97"CRC64NVMEFULL_OBJECT113474STANDARD/Inpharmd_Response20250807-38385-3jo42s.doc2025-08-07T13:04:31.000Z"a54cbdfa8b8eed7d19235b027c65bf77"CRC64NVMEFULL_OBJECT122531STANDARD/Inpharmd_Response20250807-38385-3kld7s.doc2025-08-07T12:49:15.000Z"636c1703394f8d4ddbbf0676cecf1e41"CRC64NVMEFULL_OBJECT122367STANDARD/Inpharmd_Response20250807-38385-3o3fqi.doc2025-08-07T13:32:29.000Z"469f07dbe977e8073511d56dc6daefb9"CRC64NVMEFULL_OBJECT157454STANDARD/Inpharmd_Response20250807-38385-3oqof3.doc2025-08-07T11:31:40.000Z"4d6cf899d3b63508ab79b0678e140cab"CRC64NVMEFULL_OBJECT122589STANDARD/Inpharmd_Response20250807-38385-49fhx1.doc2025-08-07T11:32:54.000Z"7c40bcbf52999de79a52d65e2e79bd0e"CRC64NVMEFULL_OBJECT122637STANDARD/Inpharmd_Response20250807-38385-4l3pwd.doc2025-08-07T11:25:30.000Z"c06f06de2c564431dddfca19cb5a79d4"CRC64NVMEFULL_OBJECT122437STANDARD/Inpharmd_Response20250807-38385-4lfvcq.doc2025-08-07T11:18:06.000Z"bb1ca888ed145126cb1abe3c05b8873d"CRC64NVMEFULL_OBJECT122367STANDARD/Inpharmd_Response20250807-38385-50ebw5.doc2025-08-07T11:53:39.000Z"af99843f2362eedb3fc55374235d4209"CRC64NVMEFULL_OBJECT122430STANDARD/Inpharmd_Response20250807-38385-5e5xph.doc2025-08-07T12:47:42.000Z"e6012a21c9b48050a35b1aae0ad28af0"CRC64NVMEFULL_OBJECT122419STANDARD/Inpharmd_Response20250807-38385-60co0q.doc2025-08-07T13:17:02.000Z"ca1b6ba0e0907e0901f3fd086bead30e"CRC64NVMEFULL_OBJECT122386STANDARD/Inpharmd_Response20250807-38385-66dryk.doc2025-08-07T10:38:27.000Z"ab475e20d6e03f49195c291b4e28ba45"CRC64NVMEFULL_OBJECT113494STANDARD/Inpharmd_Response20250807-38385-66mvgb.doc2025-08-07T13:33:09.000Z"a3ce70d23134a4c53fe7332bfd5a6e12"CRC64NVMEFULL_OBJECT122395STANDARD/Inpharmd_Response20250807-38385-6bzd5c.doc2025-08-07T13:24:42.000Z"d0dea1d6bab9261b476f035b9883c66a"CRC64NVMEFULL_OBJECT122456STANDARD/Inpharmd_Response20250807-38385-6khgjo.doc2025-08-07T10:02:25.000Z"5544976205946fe159da1c18293bb122"CRC64NVMEFULL_OBJECT122385STANDARD/Inpharmd_Response20250807-38385-7vixzd.doc2025-08-07T10:27:41.000Z"c57ba16cbb48d7c63ea211d99103b8d4"CRC64NVMEFULL_OBJECT122365STANDARD/Inpharmd_Response20250807-38385-8pwjld.doc2025-08-07T13:05:34.000Z"10b56f5afdadbb41aa55c72e5314bfe3"CRC64NVMEFULL_OBJECT122533STANDARD/Inpharmd_Response20250807-38385-90s6m0.doc2025-08-07T13:28:29.000Z"f4c0770b4553d36e51cb8592e173763d"CRC64NVMEFULL_OBJECT122567STANDARD/Inpharmd_Response20250807-38385-92q0d1.doc2025-08-07T14:02:44.000Z"b6064b6b02b7675afb4aec09837c316a"CRC64NVMEFULL_OBJECT122407STANDARD/Inpharmd_Response20250807-38385-9isq0l.doc2025-08-07T12:44:26.000Z"a8c858afe45f9e7e37997b7bbc1387ca"CRC64NVMEFULL_OBJECT122369STANDARD/Inpharmd_Response20250807-38385-aapxuc.doc2025-08-07T10:18:15.000Z"a79a959571f3a91a7b179fc5a56b0db8"CRC64NVMEFULL_OBJECT122364STANDARD/Inpharmd_Response20250807-38385-agzu1v.doc2025-08-07T10:36:35.000Z"14a0e384b41a9f41cb1ba2cb55ce6fee"CRC64NVMEFULL_OBJECT113477STANDARD/Inpharmd_Response20250807-38385-aoemal.doc2025-08-07T13:29:41.000Z"3f780bdabd2fbd1159deffa77fb3aa97"CRC64NVMEFULL_OBJECT122424STANDARD/Inpharmd_Response20250807-38385-azzd7z.doc2025-08-07T11:18:52.000Z"8be5d0bda0e65a05d5eb1953c8ee0fea"CRC64NVMEFULL_OBJECT122400STANDARD/Inpharmd_Response20250807-38385-b1827h.doc2025-08-07T13:54:53.000Z"a646941c46ba8d527682c342f06e69b8"CRC64NVMEFULL_OBJECT122464STANDARD/Inpharmd_Response20250807-38385-b3y64q.doc2025-08-07T12:06:07.000Z"1e4182fc8d48a42ff8c8470d9316f00e"CRC64NVMEFULL_OBJECT122365STANDARD/Inpharmd_Response20250807-38385-badk3u.doc2025-08-07T13:12:34.000Z"67d8b384ef5d0d81413228836d903739"CRC64NVMEFULL_OBJECT122366STANDARD/Inpharmd_Response20250807-38385-c4pb5f.doc2025-08-07T13:07:42.000Z"ab75c202539bcd20d92d46dc6c53f16b"CRC64NVMEFULL_OBJECT122602STANDARD/Inpharmd_Response20250807-38385-d34f4v.doc2025-08-07T12:55:54.000Z"b2e0b9f9cf692b9448e7bdc591c0b3cc"CRC64NVMEFULL_OBJECT122381STANDARD/Inpharmd_Response20250807-38385-dfzulp.doc2025-08-07T12:54:20.000Z"336057a957b0cc7ad1b5d126ad2743d3"CRC64NVMEFULL_OBJECT122460STANDARD/Inpharmd_Response20250807-38385-dhz08z.doc2025-08-07T13:03:23.000Z"f2121028dff92928ae26c3036bb0dddc"CRC64NVMEFULL_OBJECT122511STANDARD/Inpharmd_Response20250807-38385-e92r4t.doc2025-08-07T13:05:55.000Z"c457e874c45459e0eb2e1e36da5d159e"CRC64NVMEFULL_OBJECT122555STANDARD/Inpharmd_Response20250807-38385-eh1fmh.doc2025-08-07T11:14:55.000Z"5ca6f7c835720d6934a4894c930eb736"CRC64NVMEFULL_OBJECT122373STANDARD/Inpharmd_Response20250807-38385-f8ihx9.doc2025-08-07T13:27:07.000Z"77d2855e20d410ef39dd2e329310ba06"CRC64NVMEFULL_OBJECT122398STANDARD/Inpharmd_Response20250807-38385-ffrqio.doc2025-08-07T13:08:10.000Z"cdda79302fd5028e4ae568ce33a0a28a"CRC64NVMEFULL_OBJECT122417STANDARD/Inpharmd_Response20250807-38385-fmvzbl.doc2025-08-07T13:19:13.000Z"bb5ec6189726f71a092538563900ef91"CRC64NVMEFULL_OBJECT122363STANDARD/Inpharmd_Response20250807-38385-fqo9jw.doc2025-08-07T11:28:31.000Z"cc3850949b14526a98f9e82c7c3e430c"CRC64NVMEFULL_OBJECT122397STANDARD/Inpharmd_Response20250807-38385-g1c7ri.doc2025-08-07T12:51:49.000Z"920da340771e0de9bb376b5409075eff"CRC64NVMEFULL_OBJECT122396STANDARD/Inpharmd_Response20250807-38385-g4dkgo.doc2025-08-07T12:52:35.000Z"5759896de454fe611a5675b331c87317"CRC64NVMEFULL_OBJECT122397STANDARD/Inpharmd_Response20250807-38385-hmzfwa.doc2025-08-07T11:19:57.000Z"df90a469f478907a83be522c8dd70956"CRC64NVMEFULL_OBJECT122426STANDARD/Inpharmd_Response20250807-38385-i1atvo.doc2025-08-07T11:30:17.000Z"4c4e7c5ca76e7f65921d0287a51d7e79"CRC64NVMEFULL_OBJECT122561STANDARD/Inpharmd_Response20250807-38385-i6he28.doc2025-08-07T11:20:36.000Z"995b1b75f794117446bf52ae30d27519"CRC64NVMEFULL_OBJECT122399STANDARD/Inpharmd_Response20250807-38385-ip729w.doc2025-08-07T11:27:56.000Z"8df2400e789552623cbb5212104251a3"CRC64NVMEFULL_OBJECT122395STANDARD/Inpharmd_Response20250807-38385-iqeol9.doc2025-08-07T12:57:06.000Z"e4e198825c52e70c5fd172f042f24db0"CRC64NVMEFULL_OBJECT122388STANDARD/Inpharmd_Response20250807-38385-ivhkub.doc2025-08-07T10:40:51.000Z"a75ac75f4d113963ff53b64b4ca1dd7c"CRC64NVMEFULL_OBJECT113500STANDARD/Inpharmd_Response20250807-38385-j3ainx.doc2025-08-07T13:09:29.000Z"c67b879be8a5dd00a679614b5375cb0f"CRC64NVMEFULL_OBJECT122418STANDARD/Inpharmd_Response20250807-38385-jjle51.doc2025-08-07T11:35:45.000Z"a671f5fc53af8d9341e1d45c1ccbb893"CRC64NVMEFULL_OBJECT122394STANDARD/Inpharmd_Response20250807-38385-jlccxj.doc2025-08-07T12:55:14.000Z"0ac38aac715586872324de6984a0c437"CRC64NVMEFULL_OBJECT122415STANDARD/Inpharmd_Response20250807-38385-jmesto.doc2025-08-07T13:00:04.000Z"78022c094b807ee11e3dbeae6cb27a43"CRC64NVMEFULL_OBJECT122425STANDARD/Inpharmd_Response20250807-38385-jpgy5y.doc2025-08-07T13:23:52.000Z"453da47b8d93fec98eef7a395173fc62"CRC64NVMEFULL_OBJECT122417STANDARD/Inpharmd_Response20250807-38385-jvb6dr.doc2025-08-07T10:29:12.000Z"5824c53ecefd2e7c41cbfedfe7ab48d5"CRC64NVMEFULL_OBJECT122529STANDARD/Inpharmd_Response20250807-38385-jwre5a.doc2025-08-07T10:26:20.000Z"8e1f10682deb74bd1f01f2500b4c1656"CRC64NVMEFULL_OBJECT122588STANDARD/Inpharmd_Response20250807-38385-k4g30v.doc2025-08-07T12:57:54.000Z"d772d538431e3c078e13434b978a7012"CRC64NVMEFULL_OBJECT122414STANDARD/Inpharmd_Response20250807-38385-lq6480.doc2025-08-07T13:35:36.000Z"156d3a882d8ef70165b8ad5e3aee9f8c"CRC64NVMEFULL_OBJECT122372STANDARD/Inpharmd_Response20250807-38385-m94vr.doc2025-08-07T11:22:12.000Z"96a2c7c6d0e64d54728f86e96caa3e47"CRC64NVMEFULL_OBJECT122403STANDARD/Inpharmd_Response20250807-38385-njk6el.doc2025-08-07T13:02:42.000Z"e8097b70d8cfc6825884e84c7841d834"CRC64NVMEFULL_OBJECT122437STANDARD/Inpharmd_Response20250807-38385-nlhxxy.doc2025-08-07T13:15:40.000Z"ad5ff15b0aadd61968973a574cd9cda9"CRC64NVMEFULL_OBJECT122365STANDARD/Inpharmd_Response20250807-38385-nzaznu.doc2025-08-07T13:51:45.000Z"d2ce87d5931d9ec07c1e21bb29ea3dfb"CRC64NVMEFULL_OBJECT122402STANDARD/Inpharmd_Response20250807-38385-o7f3g5.doc2025-08-07T13:37:22.000Z"8069057374f1c891e82eeffb60314e7e"CRC64NVMEFULL_OBJECT122436STANDARD/Inpharmd_Response20250807-38385-oatrrs.doc2025-08-07T13:25:41.000Z"b7fef63de1d70f19845163214a5665f5"CRC64NVMEFULL_OBJECT122448STANDARD/Inpharmd_Response20250807-38385-ohsym9.doc2025-08-07T11:32:19.000Z"8b52354dc8f10752545c649a271eb6fe"CRC64NVMEFULL_OBJECT122562STANDARD/Inpharmd_Response20250807-38385-olab12.doc2025-08-07T11:31:14.000Z"f814a70f7e3c48aa9fc41d19aa33b6fa"CRC64NVMEFULL_OBJECT122575STANDARD/Inpharmd_Response20250807-38385-ovkxul.doc2025-08-07T11:24:24.000Z"d15526e494349ce2d2ffb6018bcc02ea"CRC64NVMEFULL_OBJECT122436STANDARD/Inpharmd_Response20250807-38385-peyiye.doc2025-08-07T13:00:30.000Z"3ce08a7201fb07ad8ababc74c06f5fd6"CRC64NVMEFULL_OBJECT122403STANDARD/Inpharmd_Response20250807-38385-raesnd.doc2025-08-07T10:14:16.000Z"09712fbcaebe5ef57d59339574017657"CRC64NVMEFULL_OBJECT113444STANDARD/Inpharmd_Response20250807-38385-raquc9.doc2025-08-07T10:12:56.000Z"e592ec6051eb246dde587d01981883b0"CRC64NVMEFULL_OBJECT113161STANDARD/Inpharmd_Response20250807-38385-rzd8wb.doc2025-08-07T12:18:47.000Z"00d582424de4671e4888cb91afa7ea7a"CRC64NVMEFULL_OBJECT122407STANDARD/Inpharmd_Response20250807-38385-s5dy6w.doc2025-08-07T13:51:04.000Z"04dc2627a586011ec4e4388d2a62cb99"CRC64NVMEFULL_OBJECT122408STANDARD/Inpharmd_Response20250807-38385-s81m4e.doc2025-08-07T13:16:08.000Z"ec8c2f98f46722cd18f3010ce11cbf71"CRC64NVMEFULL_OBJECT122438STANDARD/Inpharmd_Response20250807-38385-sap2r7.doc2025-08-07T13:01:10.000Z"a0b4df2665a3bc3be54e086a39a0a49f"CRC64NVMEFULL_OBJECT122427STANDARD/Inpharmd_Response20250807-38385-sj68mh.doc2025-08-07T11:24:56.000Z"c95ca7b86a4f17e69de8b160fa6b6097"CRC64NVMEFULL_OBJECT122435STANDARD/Inpharmd_Response20250807-38385-sjntk.doc2025-08-07T10:17:07.000Z"2723999fe8514bb7a20204fec0a7292f"CRC64NVMEFULL_OBJECT113340STANDARD/Inpharmd_Response20250807-38385-sqk38f.doc2025-08-07T13:03:22.000Z"d6c976b3330d830e205e0cb8680d2d89"CRC64NVMEFULL_OBJECT122512STANDARD/Inpharmd_Response20250807-38385-t1jxha.doc2025-08-07T11:29:04.000Z"d84ad495b128d6f4b75999748e66e06a"CRC64NVMEFULL_OBJECT122425STANDARD/Inpharmd_Response20250807-38385-t2akb0.doc2025-08-07T13:31:47.000Z"68f629a2836faf3fac1b7fb05c423917"CRC64NVMEFULL_OBJECT122458STANDARD/Inpharmd_Response20250807-38385-t5h48e.doc2025-08-07T11:13:24.000Z"b3f971eec9d3dd0806bd35370378573a"CRC64NVMEFULL_OBJECT113335STANDARD/Inpharmd_Response20250807-38385-t8dl6l.doc2025-08-07T13:13:05.000Z"4b0321b56813c9b9cb6ab50a0bd21525"CRC64NVMEFULL_OBJECT122391STANDARD/Inpharmd_Response20250807-38385-t9vij3.doc2025-08-07T10:04:21.000Z"c2dbf2d24c32855ab1a95afc15284ae1"CRC64NVMEFULL_OBJECT113449STANDARD/Inpharmd_Response20250807-38385-taka1o.doc2025-08-07T11:38:50.000Z"89d9a6ac4c187e2881f92e3aeb40f8c7"CRC64NVMEFULL_OBJECT122412STANDARD/Inpharmd_Response20250807-38385-ts1739.doc2025-08-07T13:11:54.000Z"fbca5d0e4b9d0d5a2da150c0b3e2d874"CRC64NVMEFULL_OBJECT122398STANDARD/Inpharmd_Response20250807-38385-ux3y9u.doc2025-08-07T13:50:44.000Z"f65a4cadd4924314df2dca48a8b4e2fa"CRC64NVMEFULL_OBJECT122431STANDARD/Inpharmd_Response20250807-38385-uzfipq.doc2025-08-07T10:35:52.000Z"3f6614e945fff16afdb9f8eb15bffac0"CRC64NVMEFULL_OBJECT113480STANDARD/Inpharmd_Response20250807-38385-v0twb5.doc2025-08-07T12:15:40.000Z"8b19043395b7ee139b2845eb52a70afa"CRC64NVMEFULL_OBJECT122375STANDARD/Inpharmd_Response20250807-38385-v1c95.doc2025-08-07T11:16:52.000Z"4c0225513f6b200fa9d3cdbab86381fc"CRC64NVMEFULL_OBJECT122350STANDARD/Inpharmd_Response20250807-38385-v6dfec.doc2025-08-07T11:15:58.000Z"f12e1fb7406e1a87a1462a00c718bc23"CRC64NVMEFULL_OBJECT122375STANDARD/Inpharmd_Response20250807-38385-wco0u3.doc2025-08-07T10:34:08.000Z"d8f53902831b2e59d26b78ae3c8c6eff"CRC64NVMEFULL_OBJECT113475STANDARD/Inpharmd_Response20250807-38385-wr80ip.doc2025-08-07T12:46:19.000Z"2184490d3638bc1847cd95859c444f46"CRC64NVMEFULL_OBJECT122397STANDARD/Inpharmd_Response20250807-38385-wzs4yy.doc2025-08-07T11:39:32.000Z"b8617373d03eebc3c517e16b7637a5a8"CRC64NVMEFULL_OBJECT122431STANDARD/Inpharmd_Response20250807-38385-x5zt7o.doc2025-08-07T10:31:45.000Z"68cc4fc579b36e74b6b48ee799b2a152"CRC64NVMEFULL_OBJECT113479STANDARD/Inpharmd_Response20250807-38385-y7hqzs.doc2025-08-07T13:54:21.000Z"3746ff944a7e5989c5a63718b1bc7239"CRC64NVMEFULL_OBJECT122445STANDARD/Inpharmd_Response20250807-38385-z2gn2d.doc2025-08-07T11:22:48.000Z"dc8361d102f29dec451f7d8b94edaaca"CRC64NVMEFULL_OBJECT122427STANDARD/Inpharmd_Response20250807-38385-z5wqf1.doc2025-08-07T10:12:38.000Z"84d7f455d2e2625053e8d2f7923dda5d"CRC64NVMEFULL_OBJECT113161STANDARD/Inpharmd_Response20250807-38385-znkc1m.doc2025-08-07T13:21:51.000Z"215fe8d9c9dfa913eea40be0486b68b9"CRC64NVMEFULL_OBJECT122397STANDARD/Inpharmd_Response20250807-38385-zxyj3v.doc2025-08-07T11:26:01.000Z"036bc65bd3dedff46f0025d964299a76"CRC64NVMEFULL_OBJECT122423STANDARD/Inpharmd_Response20251215-17330-gl0lez.doc2025-12-15T06:08:22.000Z"e0c2f4cc4007817842b51801af2f3932"CRC64NVMEFULL_OBJECT186781STANDARD/Inpharmd_Response20251215-22480-6jm222.doc2025-12-15T07:27:44.000Z"e1c3623d4e477a1048391aaa910d9d5a"CRC64NVMEFULL_OBJECT182846STANDARD/Inpharmd_Response20251215-25103-qm1u38.doc2025-12-15T08:40:01.000Z"a9610d8451113b5760901610cbf314a9"CRC64NVMEFULL_OBJECT183894STANDARD/Inpharmd_Response20251215-27311-785yrv.doc2025-12-15T09:03:15.000Z"dea6815076a6a8c636477c7a285ab208"CRC64NVMEFULL_OBJECT187007STANDARD/Inpharmd_Response20251215-34505-q9d1jc.doc2025-12-15T09:58:39.000Z"cf50b0b93003db081cea2264d1c8383d"CRC64NVMEFULL_OBJECT182453STANDARD/Inpharmd_Response20251215-34505-qwuepc.doc2025-12-15T10:00:54.000Z"4662fb46031108f598684ced5227b355"CRC64NVMEFULL_OBJECT191477STANDARD/Inpharmd_Response20251215-47429-4y2v7f.doc2025-12-15T13:09:53.000Z"c09d47df26fca6f7c902bc1e908e2113"CRC64NVMEFULL_OBJECT185043STANDARD/Inpharmd_Response20251215-47983-xp481e.doc2025-12-15T13:14:31.000Z"1f9520a09e79adac7d5c574fc8e862cd"CRC64NVMEFULL_OBJECT188903STANDARD/Inpharmd_Response20251215-48315-24a5h2.doc2025-12-15T16:53:48.000Z"f9bfe7c22eb439b79f8c9006797a9d0b"CRC64NVMEFULL_OBJECT184640STANDARD/Inpharmd_Response20251215-48315-2opcai.doc2025-12-15T13:25:09.000Z"c3463e70bdd5debd379543a7ac0a6149"CRC64NVMEFULL_OBJECT182605STANDARD/Inpharmd_Response20251215-48315-pgdvg.doc2025-12-15T13:22:03.000Z"3ad9b2a8f69c021a4e50f6d499f62c06"CRC64NVMEFULL_OBJECT160376STANDARD/Inpharmd_Response20251215-52934-4qsn2v.doc2025-12-15T17:26:57.000Z"fc75345f75f6967352b4f6995d9f4b83"CRC64NVMEFULL_OBJECT183929STANDARD/Inpharmd_Response20251215-52934-o4w4y2.doc2025-12-15T18:15:37.000Z"b5015b6d4327644ad50102baf21729ba"CRC64NVMEFULL_OBJECT185781STANDARD/Inpharmd_Response20251215-52934-t3w9eo.doc2025-12-15T17:30:27.000Z"0fd93a245f4a9a634c33c3b18884b5d9"CRC64NVMEFULL_OBJECT160792STANDARD/Inpharmd_Response20251215-52934-v3kmnt.doc2025-12-15T18:05:05.000Z"d370ff78f5e9df3ba364596e59f1c255"CRC64NVMEFULL_OBJECT185845STANDARD/Inpharmd_Response20251215-52934-vd7t5o.doc2025-12-15T17:25:32.000Z"47caa222a241b7e9fc8929060675c3c1"CRC64NVMEFULL_OBJECT158455STANDARD/Inpharmd_Response20251216-57772-6rth5g.doc2025-12-15T18:37:39.000Z"45e3bb0dc6bb164fb60984c7a80a076f"CRC64NVMEFULL_OBJECT184782STANDARD/Inpharmd_Response20251216-58120-mcqy22.doc2025-12-15T19:05:10.000Z"ca8763408abc01b565dc44826921fd45"CRC64NVMEFULL_OBJECT188623STANDARD/Inpharmd_Response20251216-65024-pyjsr8.doc2025-12-16T05:50:31.000Z"f4a6b9a3779fa905846818f5317bf629"CRC64NVMEFULL_OBJECT194963STANDARD/Inpharmd_Response20251216-69277-g5z4mj.doc2025-12-16T07:04:15.000Z"82eebd49050d471a783edfdec38677fb"CRC64NVMEFULL_OBJECT183132STANDARD/Inpharmd_Response20251216-69689-ferrq2.doc2025-12-16T07:10:09.000Z"e9a29993307bfeb87f5bd743f5be4ff6"CRC64NVMEFULL_OBJECT183718STANDARD/Inpharmd_Response20251216-70571-60am0s.doc2025-12-16T08:43:44.000Z"dc9a4cbe0a65dbf69482977445892a61"CRC64NVMEFULL_OBJECT187573STANDARD/Inpharmd_Response20251216-70571-9us5g0.doc2025-12-16T07:34:32.000Z"3a4da7c55e3ec9ff5d596983278653c0"CRC64NVMEFULL_OBJECT181666STANDARD/Inpharmd_Response20251216-70571-dse6kk.doc2025-12-16T07:35:59.000Z"97973bddff96becb05d71187cd6192ac"CRC64NVMEFULL_OBJECT185984STANDARD/Inpharmd_Response20251216-74311-e3170g.doc2025-12-16T09:04:32.000Z"d9ecfc4c132fe60aca5e050c6d642a51"CRC64NVMEFULL_OBJECT187617STANDARD/Inpharmd_Response20251216-75346-hbojrg.doc2025-12-16T09:16:15.000Z"70205a2c80a050322616ae7d41380551"CRC64NVMEFULL_OBJECT187008STANDARD/Inpharmd_Response20260107-5-fwarqz.pdf2026-01-07T11:44:27.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260107-5-jfe0ml.pdf2026-01-07T11:00:11.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260107-5-ltklgz.pdf2026-01-07T11:14:19.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260107-5-p493rp.pdf2026-01-07T11:51:02.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260107-5-qjcvhu.pdf2026-01-07T11:11:59.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260107-5-ynv8kf.pdf2026-01-07T11:45:06.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260107-7-7bw4v4.pdf2026-01-07T10:41:41.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260107-7-qjcvhu.pdf2026-01-07T09:42:28.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260107-7-tse5wi.pdf2026-01-07T09:41:59.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260107-7-xudmpd.pdf2026-01-07T09:58:15.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260107-8-15nvgp.pdf2026-01-07T09:27:34.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260107-8-4hnvdq.pdf2026-01-07T11:52:30.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260107-8-7ylk33.pdf2026-01-07T11:04:06.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260107-8-ddrqw7.pdf2026-01-07T12:26:55.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260107-8-tpwzlu.pdf2026-01-07T10:42:11.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260107-8-w0x8dl.pdf2026-01-07T10:38:15.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260108-5-8wsdg6.pdf2026-01-08T04:53:03.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260108-5-yf6jd1.pdf2026-01-08T05:19:56.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260108-5-znsoym.pdf2026-01-08T04:47:13.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260108-8-15kzc.pdf2026-01-08T04:56:35.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260108-8-1gkx1j.pdf2026-01-08T04:52:23.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260108-8-853u5l.pdf2026-01-08T04:55:40.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260108-8-c52kz5.pdf2026-01-08T04:45:17.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260108-8-e04keu.pdf2026-01-08T05:19:24.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260108-8-gfofox.pdf2026-01-08T05:17:15.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260109-6-17zt6p.pdf2026-01-09T12:22:31.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260112-5-ixz3kg.pdf2026-01-12T06:10:16.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Inpharmd_Response20260112-7-pinbp4.pdf2026-01-12T06:08:44.000Z"8c7e0b3539d5216d1e160369c773e149"CRC64NVMEFULL_OBJECT150012STANDARD/Meningococcal_Class_Review20260102-5-dd01yd.pdf2026-01-02T10:21:59.000Z"6644990d5dc37fde5455286f89718c45"CRC64NVMEFULL_OBJECT42356680STANDARD/Summary_Jemperli20251014-2848-l5vg9i.pdf2025-10-14T09:18:54.000Z"25bf1864fc96badefc33ab1471d7d2cd"CRC64NVMEFULL_OBJECT382279STANDARDADAKVEO_NEWS.png2024-02-28T21:31:55.000Z"440d9f04559e9b5c14796d8b744c6006"559829STANDARDAmazon_Kendra_Final.png2024-11-06T09:39:26.000Z"fe13b5466bbca17725392b84d6d11493"63628STANDARDHCP logo.png2025-11-04T12:14:21.000Z"50e60a345ec43e4ed85922dda9d64088"CRC64NVMEFULL_OBJECT10416STANDARDHERNEXEOS.png2025-09-01T12:33:09.000Z"3509f99c84a310c6bcefdaa761fd0c60"CRC64NVMEFULL_OBJECT251833STANDARDInpharmd_Response_PDF/2024-12-10T06:32:25.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDInpharmd_Response_PDF/2021-correction-to-novel-guidewire-design-and-coating-for-continuous-delivery-of-adenosine-during-interventional20251014-2848-ncpldu.pdf2025-10-14T09:24:18.000Z"82cb8fa1904c2c196270f2db8e13bcf8"CRC64NVMEFULL_OBJECT27265STANDARDInpharmd_Response_PDF/774692331120251014-8427-20etxb.pdf2025-10-14T10:34:14.000Z"5cf1989a64f5c3440ae002fa0c00c209"CRC64NVMEFULL_OBJECT492432STANDARDInpharmd_Response_PDF/77469233120251014-8427-vln7m4.pdf2025-10-14T10:34:17.000Z"5cf1989a64f5c3440ae002fa0c00c209"CRC64NVMEFULL_OBJECT492432STANDARDInpharmd_Response_PDF/7746923320251014-8427-ueh1zc.pdf2025-10-14T10:34:20.000Z"5cf1989a64f5c3440ae002fa0c00c209"CRC64NVMEFULL_OBJECT492432STANDARDInpharmd_Response_PDF/BREKIYA-FDAApproval120251014-8427-e9vzat.pdf2025-10-14T09:53:00.000Z"9da7c7b12c4b0c1c3e312dcacb2cabdd"CRC64NVMEFULL_OBJECT616837STANDARDInpharmd_Response_PDF/BREKIYA-FDAApproval120251014-8427-jhxrnu.pdf2025-10-14T10:34:22.000Z"9da7c7b12c4b0c1c3e312dcacb2cabdd"CRC64NVMEFULL_OBJECT616837STANDARDInpharmd_Response_PDF/BREKIYA-FDAApproval20251014-8427-ovpusn.pdf2025-10-14T10:19:40.000Z"9da7c7b12c4b0c1c3e312dcacb2cabdd"CRC64NVMEFULL_OBJECT616837STANDARDInpharmd_Response_PDF/BREKIYA-FDAApproval20251014-8427-ovpusn20251014-8427-ekadq7.pdf2025-10-14T10:34:25.000Z"9da7c7b12c4b0c1c3e312dcacb2cabdd"CRC64NVMEFULL_OBJECT616837STANDARDInpharmd_Response_PDF/BREKIYA-FDAApproval20251014-8427-stbi8e.pdf2025-10-14T10:34:24.000Z"9da7c7b12c4b0c1c3e312dcacb2cabdd"CRC64NVMEFULL_OBJECT616837STANDARDInpharmd_Response_PDF/CopyofViscoelastic_Agents_for_orthopedic_indications_Class_Review_August_2025.docx20251014-8427-8twt41.pdf2025-10-14T10:00:03.000Z"63a488927b14dea7a24ee3e4a7407a95"CRC64NVMEFULL_OBJECT1124978STANDARDInpharmd_Response_PDF/CopyofViscoelastic_Agents_for_orthopedic_indications_Class_Review_August_2025.docx20251014-8427-c2ag1l.pdf2025-10-14T09:55:57.000Z"63a488927b14dea7a24ee3e4a7407a95"CRC64NVMEFULL_OBJECT1124978STANDARDInpharmd_Response_PDF/Filgrastim_Class_Review20260227-18179-67jpsy.pdf2026-02-27T12:08:50.000Z"4d723ad28baf5246998b59beffa90f40"CRC64NVMEFULL_OBJECT34892741STANDARDInpharmd_Response_PDF/Inpharmd_Response-2025-02-14T153837.04720251014-8427-2nkfif.pdf2025-10-14T10:45:57.000Z"15ee07286204fb8cc7efb5618fc32656"CRC64NVMEFULL_OBJECT39531STANDARDInpharmd_Response_PDF/Inpharmd_Response-2025-04-04T121607.78720251014-2848-cp4jdy.pdf2025-10-14T09:48:28.000Z"8f96bdf66c3f87e0e1aa58e3d456739c"CRC64NVMEFULL_OBJECT133095STANDARDInpharmd_Response_PDF/Inpharmd_Response-2025-04-04T121607.78720251014-8427-zk3pue.pdf2025-10-14T09:52:19.000Z"8f96bdf66c3f87e0e1aa58e3d456739c"CRC64NVMEFULL_OBJECT133095STANDARDInpharmd_Response_PDF/Inpharmd_Response120260108-35984-o4g679.pdf2026-01-08T08:49:12.000Z"c4fbf38ef99d75b9f54c096d017235e1"CRC64NVMEFULL_OBJECT213954STANDARDInpharmd_Response_PDF/Inpharmd_Response120260108-35984-pqc289.pdf2026-01-08T08:41:55.000Z"c4fbf38ef99d75b9f54c096d017235e1"CRC64NVMEFULL_OBJECT213954STANDARDInpharmd_Response_PDF/Inpharmd_Response20241210-4890-8v6b0d.pdf2024-12-10T12:56:31.000Z"d6573e8cd9305080e27d5ea1b0b8e329"180155STANDARDInpharmd_Response_PDF/Inpharmd_Response20241210-4890-9s5vhk.pdf2024-12-10T12:03:34.000Z"a0298f00018fd31ccac866f70478bc68"168500STANDARDInpharmd_Response_PDF/Inpharmd_Response20241210-4890-ewq26r.pdf2024-12-10T13:05:46.000Z"d54bf6f0c93b6c76406d271e991c68c2"178702STANDARDInpharmd_Response_PDF/Inpharmd_Response20241210-4890-gru3lx.pdf2024-12-10T13:41:59.000Z"c323f6182da73634bcf19e82b33fb248"191439STANDARDInpharmd_Response_PDF/Inpharmd_Response20241210-4890-jg3a8p.pdf2024-12-10T12:00:02.000Z"49be660269e0ebf2e7c02d8a9c3fdb60"168500STANDARDInpharmd_Response_PDF/Inpharmd_Response20241210-4890-n6r3ck.pdf2024-12-10T14:43:05.000Z"0d5549dd343e3f2421cc8574a26134de"207937STANDARDInpharmd_Response_PDF/Inpharmd_Response20241210-4890-ufuvj0.pdf2024-12-10T13:50:22.000Z"8e743d37aeec89ca4b6ae82d659da458"177997STANDARDInpharmd_Response_PDF/Inpharmd_Response20241211-8120-6pa9wq.pdf2024-12-11T05:23:29.000Z"2cd7e91273f3d96e584c3ba979a47afa"207937STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-1hg7e9.pdf2024-12-12T12:26:12.000Z"b8ba4dfadddf305f95e1e0cd92f84333"178549STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-42uzuu.pdf2024-12-12T13:12:57.000Z"f9834a3c30b31428bbc4edd0f917c7d4"183442STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-58096r.pdf2024-12-12T12:06:55.000Z"d522783c7ce506f3a438ef1e7de7f7f7"178549STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-6dzu07.pdf2024-12-12T12:16:03.000Z"d5ac657be194741d4e86b1e3a5666710"178549STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-8mdls6.pdf2024-12-12T14:46:28.000Z"18ca154e3f12a8be846fa26138fcd814"176377STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-8y2azf.pdf2024-12-12T13:16:53.000Z"79281b37fef2042cf113bbc095599ff9"183442STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-bzvspz.pdf2024-12-12T14:07:10.000Z"cfa48fe7129365829173720b44527075"167470STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-de5lsq.pdf2024-12-12T12:02:37.000Z"2fbaebb85aa8c2199cddd31051b18bbe"178549STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-dkdd0u.pdf2024-12-12T11:58:43.000Z"ad1fbc27ade0fadbe5db689cb4b12a0f"178549STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-e2w904.pdf2024-12-12T13:05:40.000Z"edb1b6307b9a7ab18c597ccc307ea509"183442STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-frkd61.pdf2024-12-12T12:02:29.000Z"1cae52906d248b978fe9ad76e01b88c6"178549STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-omhjm9.pdf2024-12-12T13:10:52.000Z"ee2c29e8d11fb1446d4678df24f6566b"183442STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-p62qji.pdf2024-12-12T12:04:46.000Z"4613921da083875316b17a35ae5dce20"178549STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-rmbid8.pdf2024-12-12T12:11:01.000Z"13ae92cff79f19a344c99e15236b991a"178549STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-wyctkx.pdf2024-12-12T12:19:08.000Z"2476182db040e2b37a18b4aee01f2e2c"178549STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-x7hxgz.pdf2024-12-12T12:10:52.000Z"87f1880e61c65e2fef44f80c779cf942"178549STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-x7lufa.pdf2024-12-12T12:00:58.000Z"0d1a366788f437047dfba447a8c0a4f9"178549STANDARDInpharmd_Response_PDF/Inpharmd_Response20241212-36956-ym8e83.pdf2024-12-12T12:09:46.000Z"87c17b1f198bfb4ff4d9495a1cb2696a"178549STANDARDInpharmd_Response_PDF/Inpharmd_Response20241213-36956-81ev2w.pdf2024-12-13T08:54:24.000Z"ba2b7db9a8cd9766ce519e91a39d730c"213425STANDARDInpharmd_Response_PDF/Inpharmd_Response20241213-58816-3ndquv.pdf2024-12-13T12:55:28.000Z"13e9fdfbf137da5eb65ef0d17d480036"185836STANDARDInpharmd_Response_PDF/Inpharmd_Response20241213-58816-efuoq2.pdf2024-12-13T13:41:43.000Z"3300cf488a7bdb6d321ea95c0644841a"185836STANDARDInpharmd_Response_PDF/Inpharmd_Response20241213-58816-fnz7x.pdf2024-12-13T12:56:01.000Z"57a28f328d90ec1edc44e115aa54eb54"185836STANDARDInpharmd_Response_PDF/Inpharmd_Response20241213-58816-h0pjpx.pdf2024-12-13T12:27:29.000Z"6bc3ff383d13b1789c08fca1b7b3bcc5"185836STANDARDInpharmd_Response_PDF/Inpharmd_Response20241213-58816-nnsf6i.pdf2024-12-13T12:25:51.000Z"f427985816044284996fc2babb57d77d"185836STANDARDInpharmd_Response_PDF/Inpharmd_Response20241213-58816-pj1590.pdf2024-12-13T12:29:16.000Z"5e038bc06f3eb908b408718d233ef8e4"185836STANDARDInpharmd_Response_PDF/Inpharmd_Response20241213-58816-sk6xe.pdf2024-12-13T12:54:12.000Z"66eeb4649ccabef23e86cdbe278ea97a"185836STANDARDInpharmd_Response_PDF/Inpharmd_Response20241213-58816-vgttwu.pdf2024-12-13T13:36:22.000Z"675e865579b3eb8ad312b7ffdccfe584"185836STANDARDInpharmd_Response_PDF/Inpharmd_Response20241213-58816-vuwy8s.pdf2024-12-13T13:37:54.000Z"c4ca911e48f452d2ca6b55996c17b664"185836STANDARDInpharmd_Response_PDF/Inpharmd_Response20241213-58816-xfviy2.pdf2024-12-13T12:58:19.000Z"4a51228874a7072ccab830c09e3df3ef"185836STANDARDInpharmd_Response_PDF/Inpharmd_Response20241220-17617-ckqxim.pdf2024-12-20T12:28:12.000Z"e1a1d2dd6a5e51e2bf15f9fad42ad09d"195163STANDARDInpharmd_Response_PDF/Inpharmd_Response20241220-17617-flikk7.pdf2024-12-20T12:36:46.000Z"f53c786daecb1b8aec89f262382195fb"195163STANDARDInpharmd_Response_PDF/Inpharmd_Response20241223-68413-2dlkm.pdf2024-12-23T12:45:41.000Z"71002b881111ac302a49b081b40dd610"204156STANDARDInpharmd_Response_PDF/Inpharmd_Response20241223-68413-5uagkk.pdf2024-12-23T12:10:33.000Z"e349b4da23915ac42bada42121f7e794"180682STANDARDInpharmd_Response_PDF/Inpharmd_Response20241224-68413-7c376d.pdf2024-12-24T12:01:56.000Z"3419d5bd840cf017142feebc0138b814"254888STANDARDInpharmd_Response_PDF/Inpharmd_Response20241224-68413-udb6w1.pdf2024-12-24T10:58:38.000Z"8d72f6c61a3962c75949b9102c553fe9"244566STANDARDInpharmd_Response_PDF/Inpharmd_Response20241224-93517-2y5lcf.pdf2024-12-24T12:37:57.000Z"38b3f36ec990b439a18c8ebfef78a1de"182396STANDARDInpharmd_Response_PDF/Inpharmd_Response20241224-93517-tfq4gb.pdf2024-12-24T12:26:53.000Z"9d503aec75386d08e90e855adb9321d6"204266STANDARDInpharmd_Response_PDF/Inpharmd_Response20241225-10100-6tqsbr.pdf2024-12-25T03:19:43.000Z"6737fec193e03121f91cf576ecd20df3"124531STANDARDInpharmd_Response_PDF/Inpharmd_Response20241225-10100-cehx3q.pdf2024-12-25T03:17:56.000Z"513977feff22ce4a4f75e85b8bd3a228"124531STANDARDInpharmd_Response_PDF/Inpharmd_Response20241225-10100-mb6law.pdf2024-12-25T03:16:24.000Z"711e52b6113d3f1c4a11407fa1f631fc"124531STANDARDInpharmd_Response_PDF/Inpharmd_Response20241225-10100-xc416i.pdf2024-12-25T03:22:50.000Z"fc116bfcf1b3c394c265aa6e95688cd7"124531STANDARDInpharmd_Response_PDF/Inpharmd_Response20241225-10100-yrmrma.pdf2024-12-25T03:08:51.000Z"638e15c0c5c4cdcad4bf21ef7d228bba"124531STANDARDInpharmd_Response_PDF/Inpharmd_Response20241226-95689-wb4fht.pdf2024-12-26T05:25:15.000Z"35368e26db4dc02d1eb5a044292709d9"217996STANDARDInpharmd_Response_PDF/Inpharmd_Response20241227-38086-6amy8g.pdf2024-12-27T12:26:39.000Z"8fbaa94860a2ff241ea2178c07afe317"211967STANDARDInpharmd_Response_PDF/Inpharmd_Response20241227-39769-idh1n9.pdf2024-12-27T13:07:43.000Z"16d5de365db352069df734df11ad9674"207046STANDARDInpharmd_Response_PDF/Inpharmd_Response20241227-39769-sjyado.pdf2024-12-27T13:13:57.000Z"3f19ca10e73a5d1d8d88d1b604e6b9d7"261454STANDARDInpharmd_Response_PDF/Inpharmd_Response20241231-45335-5qjpoe.pdf2024-12-31T10:00:21.000Z"438bc2325b8f12baa3fdd4521bbf5aae"143970STANDARDInpharmd_Response_PDF/Inpharmd_Response20241231-45335-jhhgto.pdf2024-12-31T12:20:06.000Z"9225842efb0acb93b34e6155916b6557"138771STANDARDInpharmd_Response_PDF/Inpharmd_Response20241231-45335-k6yqgf.pdf2024-12-31T10:33:57.000Z"b11c27956e74275237f7748d24c6b759"171549STANDARDInpharmd_Response_PDF/Inpharmd_Response20241231-45335-lq049y.pdf2024-12-31T10:27:41.000Z"34bced2e9f468320f1c520e561f95aab"144468STANDARDInpharmd_Response_PDF/Inpharmd_Response20241231-93321-sszvn8.pdf2024-12-31T13:39:19.000Z"0e0c3caafe93031a17090f8764264c25"194948STANDARDInpharmd_Response_PDF/Inpharmd_Response20250102-45335-bftumk.pdf2025-01-02T09:26:31.000Z"8ce26a09277af51f7d5d7112beeeed6a"138438STANDARDInpharmd_Response_PDF/Inpharmd_Response20250103-23310-y55fxc.pdf2025-01-03T06:16:05.000Z"51e53100fdfaad65218bbbc1ab1824ab"171810STANDARDInpharmd_Response_PDF/Inpharmd_Response20250103-23695-pafr28.pdf2025-01-03T13:21:47.000Z"e9d4abd29c088ac28703390f14c1e3b5"155525STANDARDInpharmd_Response_PDF/Inpharmd_Response20250103-23695-ucqrh4.pdf2025-01-03T13:10:27.000Z"da24953297dcfe83bbe26f02f8483379"151580STANDARDInpharmd_Response_PDF/Inpharmd_Response20250103-60536-h6mhc7.pdf2025-01-03T06:10:43.000Z"863205e6304e5ae36ad9a0b91aae3000"178106STANDARDInpharmd_Response_PDF/Inpharmd_Response20250103-71591-npbouu.pdf2025-01-03T06:16:37.000Z"910627cffbb0b78a80eadec1c544bcef"185204STANDARDInpharmd_Response_PDF/Inpharmd_Response20250104-26352-7xysom.pdf2025-01-04T01:58:58.000Z"276354878137a51e8dee1fff9c2c4a86"130899STANDARDInpharmd_Response_PDF/Inpharmd_Response20250104-26352-zy88yu.pdf2025-01-04T02:05:01.000Z"f1b888ce81156916d863e10637c2e783"189534STANDARDInpharmd_Response_PDF/Inpharmd_Response20250104-6714-wjbrhc.pdf2025-01-04T09:54:41.000Z"2cc15afbffbc75c1ff84aa387cf67ecb"159829STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-21735-39otc.pdf2025-01-06T10:19:34.000Z"3d5356c5995515a6722b415c33fc6d0c"173623STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-21735-bfo2kv.pdf2025-01-06T09:40:30.000Z"8f371b368bdebd7d6e48ae9daa087173"165671STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-21735-llhc5c.pdf2025-01-06T09:47:32.000Z"cb44417d99cd14a1a752b4c3a69fc77d"154366STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-25835-x0r9yb.pdf2025-01-06T12:55:59.000Z"4f39472296a5f9bc5f68223042d7c421"132830STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-15wlo0.pdf2025-01-06T12:59:14.000Z"5b4b7c68437fff2e2151ec89e1df9b89"187458STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-1hai2d.pdf2025-01-06T10:48:31.000Z"f29dc1c4abce20288cd5a3f89ba93c34"176131STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-1xv4c0.pdf2025-01-06T14:15:45.000Z"4bee374444777e00a58ec57927875cff"175975STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-45coyo.pdf2025-01-06T10:04:42.000Z"ed223256b1e359113caf86b0a5ab3154"176131STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-4tcd1c.pdf2025-01-06T12:57:28.000Z"b50a7fc9dff0efe963935c587053da9b"187431STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-83s5rm.pdf2025-01-06T13:58:51.000Z"d92144d3d1cd1f4707d5942c97f227c4"187458STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-8hzusq.pdf2025-01-06T14:14:37.000Z"7f69859b4d90e8ddbad4bbca4f7a1710"175975STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-9hvxbw.pdf2025-01-06T14:20:04.000Z"4b95cd609d8e8b89839a8807139db42a"175975STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-9idvy1.pdf2025-01-06T06:09:19.000Z"5f7560108a18467cca2936c1f6ab8b58"175956STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-b8ldni.pdf2025-01-06T14:19:13.000Z"b6142e51b419b0dcbf469fecae952f8c"175975STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-cl9e04.pdf2025-01-06T14:13:23.000Z"05d3470cb6605538d1cf53aa619c8676"175975STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-ennt9k.pdf2025-01-06T11:02:11.000Z"4d81eb89df1919c8f4f9beb50fcb4c4d"176131STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-eyegpf.pdf2025-01-06T14:22:25.000Z"82c07415e75dcb97a57ffd8d30ae372e"175975STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-ihoyz3.pdf2025-01-06T10:38:33.000Z"3adc209c08c2b41ea08a7cd4fc835499"176131STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-jo4qi6.pdf2025-01-06T14:16:49.000Z"15508506490c3ee0d4f0cf0cb6f29891"175975STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-mlmetv.pdf2025-01-06T10:12:23.000Z"86d9c199f565bec5f0215bc36911f0f2"176131STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-pp5xf0.pdf2025-01-06T10:47:28.000Z"4292a7fe55a637b577046a2b6124d6e3"176131STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-pz9v84.pdf2025-01-06T13:54:59.000Z"6987920ed7fc0bb68368ced36314d32e"177711STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-60536-u9xnjs.pdf2025-01-06T10:37:35.000Z"41998c16a580e9f80cb4edf92e8f9a81"176131STANDARDInpharmd_Response_PDF/Inpharmd_Response20250106-8047-yxthzi.pdf2025-01-06T06:43:00.000Z"a7c69ecbab3e7a0b5125b1635144c21b"163215STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-2683-6x56vp.pdf2025-01-07T12:47:18.000Z"242c5b026a7432da57b3aca7e3bc68d1"212230STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-2683-ktolm6.pdf2025-01-07T13:20:25.000Z"f66a04cb270cd3606e7ff1c114ffef2e"133418STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-2683-tyoq76.pdf2025-01-07T12:58:41.000Z"b6a67d34365d56b240beb0b53aa28e1b"132521STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-2683-yvzal.pdf2025-01-07T13:26:21.000Z"9b5133f1c5f745c3087175f1abba70a4"132259STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-3025-20bclh.pdf2025-01-07T10:22:45.000Z"9168fc66f1832976a0131457b88d5264"216071STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-3025-2sbwpu.pdf2025-01-07T10:08:10.000Z"03e2294fb9300cceb5f9e6af0e9bf399"216071STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-3025-2yltwu.pdf2025-01-07T09:59:24.000Z"c1744ac0e39983f15bffd616f9695eed"216071STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-3025-4dqcen.pdf2025-01-07T10:13:45.000Z"dd54fceea6d25c2a299838b13dd10c01"216071STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-3025-c6ethd.pdf2025-01-07T10:00:49.000Z"dadfde1e3988b4d5720b0c01ae0a705e"216071STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-3025-e0rxco.pdf2025-01-07T10:24:04.000Z"cf7e9e86bdb7200c3b391ee1c4557cc8"216071STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-3025-i7hd2p.pdf2025-01-07T10:08:48.000Z"8dc772ac5c7b7c48997e5cfe3e943522"216071STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-3025-jffrwd.pdf2025-01-07T10:54:35.000Z"da6a6f459638ff7dfc7a0062109ade40"253297STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-3025-mj91xy.pdf2025-01-07T10:38:10.000Z"6b37035da17ccbfddd82327199991dbc"216071STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-3025-oblnv0.pdf2025-01-07T10:28:06.000Z"baa29cf7a478afe4b1d8c22b846106ce"174826STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-3025-t00fam.pdf2025-01-07T10:02:58.000Z"8f0bb4e61f9eb7358537dffb777c7e0a"216071STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-3025-t5ei2l.pdf2025-01-07T11:37:56.000Z"ada5103ba56a16da1f74895cbc623da9"176480STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-3025-ux10io.pdf2025-01-07T10:04:41.000Z"19f21fe8320ed92ebd1a595d082fa51d"216071STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-47199-45pxsn.pdf2025-01-07T07:27:13.000Z"ffa9c3c9a2a26156a7b375820a79bce1"176407STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-47199-6fgil5.pdf2025-01-07T07:29:48.000Z"d3933a1c5272d4e37e829de7e779a311"176407STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-47199-8ekap7.pdf2025-01-07T07:37:46.000Z"29843a78528aa3ae6ed3dda33671e00d"176407STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-47199-8nxlga.pdf2025-01-07T09:18:34.000Z"534b96ddee0855b8c6cacf3358abe12d"216071STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-47199-8v5g31.pdf2025-01-07T07:10:54.000Z"4d673af70c7157e8dff27b8d09a6a486"215687STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-47199-aemxmi.pdf2025-01-07T09:04:34.000Z"a14a5e39c9c5e5d96d6b7fb22f0038f9"216071STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-47199-cg06az.pdf2025-01-07T09:10:22.000Z"854779a41abe2ee523b566698e914725"216071STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-47199-cv2yac.pdf2025-01-07T07:30:51.000Z"a612f057d0cf6fd3cf5e345eeb530c8b"176407STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-47199-fcyil7.pdf2025-01-07T09:12:54.000Z"76db740bbc9c5713888ea2e30d21d45e"216071STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-47199-hbtkiw.pdf2025-01-07T07:25:54.000Z"397a6f8c6924984f5ae78cd573cdad69"176407STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-47199-iuty7x.pdf2025-01-07T09:05:50.000Z"4b071eb4ef89e2a192ef5c23a53c8aa3"216071STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-47199-l2jeyl.pdf2025-01-07T07:16:46.000Z"f274a73e8eab8688dd46dfdf3849be87"176407STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-47199-lvuv46.pdf2025-01-07T08:56:14.000Z"df48f2b1f06e541f15a4401aefe0da4c"176407STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-47199-opw3iy.pdf2025-01-07T09:17:47.000Z"85c6d83f8e16e443b60e64120d9241ed"216071STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-47199-pif2sd.pdf2025-01-07T07:02:02.000Z"42dccc21408d4c52a3bd51ba404bdbf2"213550STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-47199-yq4wbq.pdf2025-01-07T07:22:31.000Z"e37d7a7d4ddd4aabb1a40fd6db1e0c3e"176407STANDARDInpharmd_Response_PDF/Inpharmd_Response20250107-49892-564d1h.pdf2025-01-07T19:01:09.000Z"e5b2489ce36bb0449aa8857e251ec6bf"142916STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-2683-6u1y1v.pdf2025-01-08T09:51:22.000Z"330974b0bc01246b2aec7001fe0a11d9"224754STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-2683-8kmjzy.pdf2025-01-08T05:11:49.000Z"f1689f380e4e2a1e057cab2db6285fd9"195653STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-2683-fjy348.pdf2025-01-08T13:02:23.000Z"ddc047be5c37431272a8db18b3f952e9"133923STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-2683-gk4yr.pdf2025-01-08T05:33:37.000Z"1d5de2cff3c523dc4313066c5a022484"134267STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-2683-hp45c.pdf2025-01-08T09:23:41.000Z"dbc54d034a23f81442b7265f1493940d"132135STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-2683-nxmrrk.pdf2025-01-08T05:14:11.000Z"e660b30a53f3719e3111226e3bf15a80"195700STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-2683-qlv52b.pdf2025-01-08T10:02:14.000Z"f209439444b3c70f90c9c6edc24e68f5"196146STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-2683-ul4ihu.pdf2025-01-08T05:22:39.000Z"e158acfac3b6df24e5f9495d90718270"133055STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-2683-xm7ktk.pdf2025-01-08T09:37:09.000Z"1344eb9a9bb0e0c46dda2afbd035899e"133068STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-2683-yqb4jr.pdf2025-01-08T09:27:15.000Z"190a37a32cbae3948c9e65cfe919964e"132135STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-3025-91ir9e.pdf2025-01-08T04:40:45.000Z"9a4fbe6a8d59426d8c3a830931227084"177711STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-3025-bbhdxr.pdf2025-01-08T04:40:08.000Z"04a8f7bf41bcfb1ea99716ab59cbb1e8"177711STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-3025-dtm04b.pdf2025-01-08T04:43:21.000Z"943139042cad0357e6a714fb6cacae19"180698STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-3025-idrw2t.pdf2025-01-08T10:15:58.000Z"42ccd0a5c78086b31b6b4ff69b80c1d0"216562STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-7352-1rgoxz.pdf2025-01-08T06:53:48.000Z"1cdb1590fba80589368d6d18c1fad212"155908STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-7352-6nf0vk.pdf2025-01-08T06:48:47.000Z"d5cc86679116bf3245398a30c3da1928"155525STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-7352-vep2d6.pdf2025-01-08T06:59:49.000Z"3d4e6512693d1170bc22008cf59d039a"157326STANDARDInpharmd_Response_PDF/Inpharmd_Response20250108-7352-vwdby4.pdf2025-01-08T06:46:00.000Z"ebd7be6a5f6809e7cf6afeaf4a231d00"155525STANDARDInpharmd_Response_PDF/Inpharmd_Response20250109-2683-25kfe7.pdf2025-01-09T06:31:51.000Z"02424882fcb57a4e34a8c05a6a0628ea"141398STANDARDInpharmd_Response_PDF/Inpharmd_Response20250109-2683-2lt30v.pdf2025-01-09T11:18:30.000Z"bef1f1175d28550691340adbd26931a4"136843STANDARDInpharmd_Response_PDF/Inpharmd_Response20250109-2683-4eww6w.pdf2025-01-09T08:50:58.000Z"b2fb68592f01b7ef927605feceaaba0d"172993STANDARDInpharmd_Response_PDF/Inpharmd_Response20250109-2683-av2j6t.pdf2025-01-09T11:17:40.000Z"942263bdab029c30efc9af349c58a26b"136843STANDARDInpharmd_Response_PDF/Inpharmd_Response20250109-2683-dtr4zo.pdf2025-01-09T12:13:28.000Z"21c453980bb8238460860ecd4fb98934"136843STANDARDInpharmd_Response_PDF/Inpharmd_Response20250109-2683-f9os2q.pdf2025-01-09T12:13:55.000Z"41366732ba775f4a41d8847dfe6cd6a4"136843STANDARDInpharmd_Response_PDF/Inpharmd_Response20250109-2683-fbtm8l.pdf2025-01-09T11:13:47.000Z"8117e3bdc338400e21c51b42a9bb36fd"136647STANDARDInpharmd_Response_PDF/Inpharmd_Response20250109-2683-hbl5dk.pdf2025-01-09T05:49:51.000Z"773f89fc6616e1590e586a63ccd76560"133109STANDARDInpharmd_Response_PDF/Inpharmd_Response20250109-2683-ju5ocf.pdf2025-01-09T07:17:53.000Z"7b06c9a18de7ac357d41c04d4942f5e0"131854STANDARDInpharmd_Response_PDF/Inpharmd_Response20250109-2683-nu08a1.pdf2025-01-09T12:12:09.000Z"25a4aecc8569a754f6be6cbb00c92e47"133181STANDARDInpharmd_Response_PDF/Inpharmd_Response20250109-2683-o10wap.pdf2025-01-09T06:58:36.000Z"5d317b0131394be5e1e9e6d8fc5c81a4"138101STANDARDInpharmd_Response_PDF/Inpharmd_Response20250109-2683-t3lq39.pdf2025-01-09T11:17:02.000Z"033b9bfdd737bbc8e7289bb5573782d9"136843STANDARDInpharmd_Response_PDF/Inpharmd_Response20250109-2683-xifho3.pdf2025-01-09T11:18:00.000Z"895cd2d1962b23a176f17427f563549a"136843STANDARDInpharmd_Response_PDF/Inpharmd_Response20250110-2683-2wh5dy.pdf2025-01-10T07:06:59.000Z"9de5d4f7737d741336b6acfea12b3e39"133402STANDARDInpharmd_Response_PDF/Inpharmd_Response20250110-2683-2zwmpy.pdf2025-01-10T09:21:30.000Z"3e1a2bf5044026284b23bc78b8711b82"132416STANDARDInpharmd_Response_PDF/Inpharmd_Response20250110-2683-cpqhw3.pdf2025-01-10T09:05:11.000Z"f1fd441058e756c97c0b0df28c5df0ec"139917STANDARDInpharmd_Response_PDF/Inpharmd_Response20250110-2683-dmnafh.pdf2025-01-10T09:09:11.000Z"bac0ec445b248f27efd9a30f89d9495f"139960STANDARDInpharmd_Response_PDF/Inpharmd_Response20250110-2683-epxkxf.pdf2025-01-10T09:18:41.000Z"4e1e7c30a260e5255f164ee290c6e5c8"132416STANDARDInpharmd_Response_PDF/Inpharmd_Response20250110-2683-it8zqv.pdf2025-01-10T06:56:48.000Z"9970007e39a00d71a20372d2479456f8"136843STANDARDInpharmd_Response_PDF/Inpharmd_Response20250110-2683-kpkumi.pdf2025-01-10T09:12:03.000Z"932bbc385d31f80222a66937816e23ab"139960STANDARDInpharmd_Response_PDF/Inpharmd_Response20250110-2683-oi7no6.pdf2025-01-10T09:40:33.000Z"e8c494d7b305a7f13a098f241ee861cb"134011STANDARDInpharmd_Response_PDF/Inpharmd_Response20250110-2683-qk3kw1.pdf2025-01-10T09:10:08.000Z"d1c90c5150fd7812bb44ebc2c3c3b7b4"139960STANDARDInpharmd_Response_PDF/Inpharmd_Response20250110-2683-uj4v80.pdf2025-01-10T09:16:37.000Z"f5bc5e73da66bf8428b67515c02dd030"132223STANDARDInpharmd_Response_PDF/Inpharmd_Response20250110-2683-zvg1rf.pdf2025-01-10T09:09:27.000Z"451cc1659fc0daae20f812467a4764da"139960STANDARDInpharmd_Response_PDF/Inpharmd_Response20250110-38851-7i2p7a.pdf2025-01-10T09:50:29.000Z"c4fb5f6976720f31aaa0fba619d170b5"183487STANDARDInpharmd_Response_PDF/Inpharmd_Response20250110-38851-8tmt4z.pdf2025-01-10T09:50:45.000Z"c3204a310935a736112081bca1c6a4e2"183487STANDARDInpharmd_Response_PDF/Inpharmd_Response20250115-1854-4xgmyh.pdf2025-01-15T10:14:48.000Z"a4d5f6185cd36417b74c16cef5fc1488"195868STANDARDInpharmd_Response_PDF/Inpharmd_Response20250115-1854-6vrfmx.pdf2025-01-15T06:36:01.000Z"e9b4889bcc5a399831736ac38dbddf02"163376STANDARDInpharmd_Response_PDF/Inpharmd_Response20250115-1854-a3afvj.pdf2025-01-15T11:12:19.000Z"3a34c8d951aa79ae617aaef0dfdbba9f"134463STANDARDInpharmd_Response_PDF/Inpharmd_Response20250115-1854-bbp2kq.pdf2025-01-15T09:39:00.000Z"67e617c3bd808c58cdc4907b4e252a34"143996STANDARDInpharmd_Response_PDF/Inpharmd_Response20250115-1854-f6f4mi.pdf2025-01-15T07:03:36.000Z"57a3df0eb5f87ae9f3b8228f10e8849e"159273STANDARDInpharmd_Response_PDF/Inpharmd_Response20250115-1854-jlzhfo.pdf2025-01-15T09:42:18.000Z"9ddb3128590e552b739961ddef6ed192"144042STANDARDInpharmd_Response_PDF/Inpharmd_Response20250115-1854-tx6ebf.pdf2025-01-15T11:17:54.000Z"8c6c51ef5d95563990b8d0ff458d6750"134463STANDARDInpharmd_Response_PDF/Inpharmd_Response20250115-1854-w4251b.pdf2025-01-15T11:09:59.000Z"7150f237be0dd78b1200f8380b6058ee"134263STANDARDInpharmd_Response_PDF/Inpharmd_Response20250115-1854-xiekl1.pdf2025-01-15T06:47:10.000Z"4201051637fe3ffc64c0b23202c98563"163423STANDARDInpharmd_Response_PDF/Inpharmd_Response20250115-38851-au15l1.pdf2025-01-15T09:08:56.000Z"f587343221927df81ff0beaf996f4000"184280STANDARDInpharmd_Response_PDF/Inpharmd_Response20250115-38851-ead6i6.pdf2025-01-15T09:12:58.000Z"79d87ff323de104bafb7f0f67e629b9f"184329STANDARDInpharmd_Response_PDF/Inpharmd_Response20250115-38851-ospb0v.pdf2025-01-15T09:28:11.000Z"27655e134c34ab15d920de872691f761"184329STANDARDInpharmd_Response_PDF/Inpharmd_Response20250115-38851-swj1vj.pdf2025-01-15T09:27:53.000Z"0cb15a3a88d16640f7cda0ab1399ca22"184329STANDARDInpharmd_Response_PDF/Inpharmd_Response20250115-61929-cf9pjs.pdf2025-01-15T10:50:39.000Z"2aeb18699fce1ffd5c414b44a7a20c8c"184329STANDARDInpharmd_Response_PDF/Inpharmd_Response20250115-61929-nstlaw.pdf2025-01-15T11:06:18.000Z"50da0b452ccb8e4fe976ed3ff5c2020c"183520STANDARDInpharmd_Response_PDF/Inpharmd_Response20250116-78644-4p2dex.pdf2025-01-16T12:05:44.000Z"41bf4227bc1f0bee708b1d3037b240e0"179852STANDARDInpharmd_Response_PDF/Inpharmd_Response20250117-78644-1zfj4g.pdf2025-01-17T05:43:46.000Z"d328f00a738c1afd46daf8a16c5b0890"185145STANDARDInpharmd_Response_PDF/Inpharmd_Response20250117-78644-go1k7o.pdf2025-01-17T05:32:08.000Z"03c3facc14480819b109388155a3c553"261504STANDARDInpharmd_Response_PDF/Inpharmd_Response20250117-78644-lo7o0r.pdf2025-01-17T08:46:06.000Z"43dab71358ae109d9451b9ae3c470b3f"183520STANDARDInpharmd_Response_PDF/Inpharmd_Response20250117-78644-qjduls.pdf2025-01-17T05:09:09.000Z"986eff4ada06369b58967ac00bfc8d4a"261504STANDARDInpharmd_Response_PDF/Inpharmd_Response20250117-78644-r9wo3j.pdf2025-01-17T05:35:29.000Z"af7c36acce2ce55da662384c7a1562dc"175385STANDARDInpharmd_Response_PDF/Inpharmd_Response20250122-1862-ptedtw.pdf2025-01-22T10:26:09.000Z"a53c5760a323524251ce3216d11949e2"207590STANDARDInpharmd_Response_PDF/Inpharmd_Response20250122-1862-sf7hjg.pdf2025-01-22T12:12:30.000Z"6e2b39b57aa6d5e0ed7b2993e98d9660"203288STANDARDInpharmd_Response_PDF/Inpharmd_Response20250123-10134-724tvo.pdf2025-01-23T14:01:49.000Z"4b9f4711db37e44e8ab68a274769cfa4"164008STANDARDInpharmd_Response_PDF/Inpharmd_Response20250124-10134-njunck.pdf2025-01-24T09:53:53.000Z"13b3a7ecc34c6ec90f42d21dd2ba81da"158289STANDARDInpharmd_Response_PDF/Inpharmd_Response20250124-22253-3dacyd.pdf2025-01-24T12:27:04.000Z"80656bbbe35514956750becc1e8c345f"177409STANDARDInpharmd_Response_PDF/Inpharmd_Response20250124-22253-c1f2oa.pdf2025-01-24T12:17:26.000Z"b74dc741c57f9c73fc0a36491b0d6094"177297STANDARDInpharmd_Response_PDF/Inpharmd_Response20250124-22253-pvk25p.pdf2025-01-24T10:02:53.000Z"e3bcb5d32e30716310b5c54ba30ab55a"166579STANDARDInpharmd_Response_PDF/Inpharmd_Response20250127-9941-5y7kvd.pdf2025-01-27T07:13:56.000Z"25ebd102ca5247d7a31d0290ac0692d2"164440STANDARDInpharmd_Response_PDF/Inpharmd_Response20250127-9941-89j17s.pdf2025-01-27T07:07:25.000Z"ab6b27fb605f30f10779c392d624bef8"164440STANDARDInpharmd_Response_PDF/Inpharmd_Response20250127-9941-byo215.pdf2025-01-27T08:43:09.000Z"3e4ba6c06bbf9b5663080a706c0791ec"164440STANDARDInpharmd_Response_PDF/Inpharmd_Response20250127-9941-esqdnl.pdf2025-01-27T06:58:20.000Z"eb51076cf5d106e984b23d82acc0eb87"164395STANDARDInpharmd_Response_PDF/Inpharmd_Response20250127-9941-h7hnud.pdf2025-01-27T09:25:15.000Z"220c69474a4910597beeb14567fdcd13"164440STANDARDInpharmd_Response_PDF/Inpharmd_Response20250127-9941-jfrbez.pdf2025-01-27T09:17:27.000Z"474b90e297d8197625ab1bea45d13307"135056STANDARDInpharmd_Response_PDF/Inpharmd_Response20250127-9941-jn81ww.pdf2025-01-27T08:47:04.000Z"aca6c83efd10e9f5cb7c80fdfb3ea659"168918STANDARDInpharmd_Response_PDF/Inpharmd_Response20250127-9941-le6fkg.pdf2025-01-27T07:10:35.000Z"2b5a328af7ac82aecd6923eb71793452"164440STANDARDInpharmd_Response_PDF/Inpharmd_Response20250127-9941-p19v3y.pdf2025-01-27T09:00:04.000Z"4ba55253cd0aee50534ff889792b09ef"164440STANDARDInpharmd_Response_PDF/Inpharmd_Response20250127-9941-wupdly.pdf2025-01-27T07:04:10.000Z"d9b3508a6ae000906895e8df23aa8754"164440STANDARDInpharmd_Response_PDF/Inpharmd_Response20250128-17909-o7funw.pdf2025-01-28T11:11:14.000Z"1abd82b180f47dfeb510a0222d44add6"CRC32FULL_OBJECT168710STANDARDInpharmd_Response_PDF/Inpharmd_Response20250128-24295-x8noim.pdf2025-01-28T10:47:26.000Z"39e5c1ca03ac692a6faa4430bb79b60b"217996STANDARDInpharmd_Response_PDF/Inpharmd_Response20250204-42665-d0zp93.pdf2025-02-04T21:34:21.000Z"6038502fb1009a8b1e199f32a04fdf92"144355STANDARDInpharmd_Response_PDF/Inpharmd_Response20250204-50368-cnz5jc.pdf2025-02-05T00:58:06.000Z"6f43ed8ed2074aae6a8d7b23d9323ae1"180200STANDARDInpharmd_Response_PDF/Inpharmd_Response20250205-37493-1kbmwg.pdf2025-02-05T12:42:45.000Z"ab0d09e2bb44ebf77d8b5122e410a420"182492STANDARDInpharmd_Response_PDF/Inpharmd_Response20250205-37493-lsu1od.pdf2025-02-05T12:48:02.000Z"87cb8da4496e5d4af72f4b459b90095d"175467STANDARDInpharmd_Response_PDF/Inpharmd_Response20250205-37493-r26xpz.pdf2025-02-05T14:13:48.000Z"275786d60302a2161e9ada6826d825a9"174985STANDARDInpharmd_Response_PDF/Inpharmd_Response20250207-71894-1fdumc.pdf2025-02-07T09:47:16.000Z"7d29dc1dffd9b8c39ba807356a172adb"247570STANDARDInpharmd_Response_PDF/Inpharmd_Response20250207-71894-e5l7y7.pdf2025-02-07T10:08:14.000Z"c2257c178862600a1cde7257c874d6b7"247587STANDARDInpharmd_Response_PDF/Inpharmd_Response20250207-73357-7ft84u.pdf2025-02-07T10:37:17.000Z"71d889a3700bc890b11f0368540df16e"210676STANDARDInpharmd_Response_PDF/Inpharmd_Response20250207-73357-rcwjl8.pdf2025-02-07T13:29:35.000Z"374855567e43e9c9cb96fd4e43876c5d"182493STANDARDInpharmd_Response_PDF/Inpharmd_Response20250210-50411-gm9vo.pdf2025-02-10T15:13:01.000Z"9b00c9ff7dbc7317daf8c6c5eb1b7c02"204928STANDARDInpharmd_Response_PDF/Inpharmd_Response20250211-65330-m6gug7.pdf2025-02-11T15:42:12.000Z"60edee556ec3dc8293216ef29fee7fd5"180203STANDARDInpharmd_Response_PDF/Inpharmd_Response20250211-73357-kyxlrj.pdf2025-02-11T05:22:54.000Z"ea893ece3031a988595d8045b72851d2"216154STANDARDInpharmd_Response_PDF/Inpharmd_Response20250305-57797-oi5ohe.pdf2025-03-05T16:43:34.000Z"7c13ca3ddc9a4d634823ad0b511cf058"CRC64NVMEFULL_OBJECT140762STANDARDInpharmd_Response_PDF/Inpharmd_Response20250305-57994-yhtyk0.pdf2025-03-05T16:46:40.000Z"f85df9f0212bab41f7bba2b5bb16bec6"CRC64NVMEFULL_OBJECT142519STANDARDInpharmd_Response_PDF/Inpharmd_Response20250312-73902-2b1dw2.pdf2025-03-12T19:54:03.000Z"185bf5775154dc294c1c5389dbab8533"CRC64NVMEFULL_OBJECT148928STANDARDInpharmd_Response_PDF/Inpharmd_Response20250312-77451-sh188i.pdf2025-03-12T20:16:20.000Z"382e84a6a44e6518f3a4461f2e8fbeb6"CRC64NVMEFULL_OBJECT148928STANDARDInpharmd_Response_PDF/Inpharmd_Response20250313-13400-z4bito.pdf2025-03-13T20:18:54.000Z"9fddb8ca5b0baed544fcf350831d13b8"CRC64NVMEFULL_OBJECT148928STANDARDInpharmd_Response_PDF/Inpharmd_Response20250313-14110-6zwebp.pdf2025-03-13T20:29:46.000Z"d5d0b68195b6dd8d6d01e231719d4580"CRC64NVMEFULL_OBJECT148979STANDARDInpharmd_Response_PDF/Inpharmd_Response20250313-89368-pcin44.pdf2025-03-13T04:36:24.000Z"1a0f2308cacbd2734fa5e12a7cc25246"CRC64NVMEFULL_OBJECT148928STANDARDInpharmd_Response_PDF/Inpharmd_Response20250314-14110-xtyv6q.pdf2025-03-14T12:22:39.000Z"9f482765c2aed42e04ecfc97f07e286a"CRC64NVMEFULL_OBJECT144928STANDARDInpharmd_Response_PDF/Inpharmd_Response20250410-12550-cb2sui.pdf2025-04-10T09:23:14.000Z"8dced4f03da4cd146cd5719e863d4b39"CRC64NVMEFULL_OBJECT138352STANDARDInpharmd_Response_PDF/Inpharmd_Response20250418-28880-23x8sy.doc2025-04-18T09:44:02.000Z"f22bf06389a775c7b62f3fabfc81efa2"CRC64NVMEFULL_OBJECT138028STANDARDInpharmd_Response_PDF/Inpharmd_Response20250418-28880-pqm92f.doc2025-04-18T09:38:49.000Z"a686cbf46297981f3d07bf54dea86edf"CRC64NVMEFULL_OBJECT144131STANDARDInpharmd_Response_PDF/Inpharmd_Response20250418-67316-8d66mr.doc2025-04-18T06:52:22.000Z"2145d87bdac07cd7e73b8070a0fa6b19"CRC64NVMEFULL_OBJECT117081STANDARDInpharmd_Response_PDF/Inpharmd_Response20250418-67316-xdlp54.doc2025-04-18T06:44:01.000Z"25f862280d67e15c5af2d295faaa00d2"CRC64NVMEFULL_OBJECT116844STANDARDInpharmd_Response_PDF/Inpharmd_Response20250418-67595-1ou8d1.doc2025-04-18T07:18:46.000Z"d9e0b1f85051926c9cc31ec7d48eec9c"CRC64NVMEFULL_OBJECT113515STANDARDInpharmd_Response_PDF/Inpharmd_Response20250418-67595-4e8b84.doc2025-04-18T06:57:10.000Z"ac1fb5d1c5612c3d621f9291fb1ebb04"CRC64NVMEFULL_OBJECT113320STANDARDInpharmd_Response_PDF/Inpharmd_Response20250418-67595-8rcxid.doc2025-04-18T06:54:39.000Z"ffdb71a3f9bf1fbb6a26eb8c587e1a46"CRC64NVMEFULL_OBJECT113477STANDARDInpharmd_Response_PDF/Inpharmd_Response20250418-67595-9ae59x.doc2025-04-18T07:10:31.000Z"6b31fa1d1cd94fe752563ea98a157428"CRC64NVMEFULL_OBJECT137545STANDARDInpharmd_Response_PDF/Inpharmd_Response20250418-67595-ftkwra.doc2025-04-18T06:57:56.000Z"78bc45ef8d8e99c8e771bbfbf35f2656"CRC64NVMEFULL_OBJECT113369STANDARDInpharmd_Response_PDF/Inpharmd_Response20250418-67595-p2kzzv.doc2025-04-18T07:11:09.000Z"2debe2180c89743d340d514ff4113f6d"CRC64NVMEFULL_OBJECT144757STANDARDInpharmd_Response_PDF/Inpharmd_Response20250424-6571-5o4cgz.doc2025-04-24T08:52:59.000Z"02c3cf742f6760b25673c1694bf48331"CRC64NVMEFULL_OBJECT147602STANDARDInpharmd_Response_PDF/Inpharmd_Response20250424-6571-hv4n8v.doc2025-04-24T09:13:34.000Z"cdd7755bac5d0c708ff9e8b8779fd01e"CRC64NVMEFULL_OBJECT147087STANDARDInpharmd_Response_PDF/Inpharmd_Response20250424-6571-i88uny.doc2025-04-24T08:54:15.000Z"3881e2dc5a21e50b6090af31ef1293d6"CRC64NVMEFULL_OBJECT144504STANDARDInpharmd_Response_PDF/Inpharmd_Response20250424-6571-in3qa8.doc2025-04-24T09:14:47.000Z"afa4b02df2e09080c9d7f7089a4ee5a1"CRC64NVMEFULL_OBJECT156960STANDARDInpharmd_Response_PDF/Inpharmd_Response20250424-6571-j4moi4.doc2025-04-24T09:13:10.000Z"f7d0d14b0445532966d0896f1723e4e6"CRC64NVMEFULL_OBJECT141341STANDARDInpharmd_Response_PDF/Inpharmd_Response20250424-68517-az1gcl.pdf2025-04-24T14:44:34.000Z"6bcac9c6b2e39bb0dcd9afb32d6ce13c"CRC64NVMEFULL_OBJECT194592STANDARDInpharmd_Response_PDF/Inpharmd_Response20250424-68517-cwxk23.pdf2025-04-24T14:44:43.000Z"bb3cf079e0a7dc84ea798d7abf8f64fd"CRC64NVMEFULL_OBJECT194592STANDARDInpharmd_Response_PDF/Inpharmd_Response20250425-79001-frjq8w.pdf2025-04-25T06:27:55.000Z"62f50647d21f588adfd207765dd6902c"CRC64NVMEFULL_OBJECT185243STANDARDInpharmd_Response_PDF/Inpharmd_Response20250425-79001-ngq7re.pdf2025-04-25T06:32:44.000Z"b641221273c556db44712893cc5c437f"CRC64NVMEFULL_OBJECT185243STANDARDInpharmd_Response_PDF/Inpharmd_Response20250425-79001-qn0f4h.pdf2025-04-25T06:32:36.000Z"aa350c0171139da090faa5f4a9b1394d"CRC64NVMEFULL_OBJECT185243STANDARDInpharmd_Response_PDF/Inpharmd_Response20250428-22623-8yhegs.doc2025-04-28T12:37:32.000Z"3364db52eee0aed9db0017ee24c96719"CRC64NVMEFULL_OBJECT116786STANDARDInpharmd_Response_PDF/Inpharmd_Response20250428-22623-9xid2j.doc2025-04-28T12:52:26.000Z"474a4eeac46c9fd3db76ef54e44e2dbb"CRC64NVMEFULL_OBJECT117105STANDARDInpharmd_Response_PDF/Inpharmd_Response20250428-22623-eid5bt.doc2025-04-28T12:27:17.000Z"963696e26b5d6f991cc70ba04f44d570"CRC64NVMEFULL_OBJECT142080STANDARDInpharmd_Response_PDF/Inpharmd_Response20250428-22635-zm7tk0.doc2025-04-28T12:12:50.000Z"d305fa4abb0e320ae59f97b0d6716aa2"CRC64NVMEFULL_OBJECT138117STANDARDInpharmd_Response_PDF/Inpharmd_Response20250428-27547-hvuy41.pdf2025-04-28T13:17:15.000Z"62365ab70f6641d3a3441daac5c8a856"CRC64NVMEFULL_OBJECT165461STANDARDInpharmd_Response_PDF/Inpharmd_Response20250428-27684-8uko2h.pdf2025-04-28T13:48:11.000Z"87484a8101b445d4dc2caef4ee16f579"CRC64NVMEFULL_OBJECT153807STANDARDInpharmd_Response_PDF/Inpharmd_Response20250428-27684-ca6rt7.pdf2025-04-28T13:26:44.000Z"1ba05152ab55fa59c003806a2f321d36"CRC64NVMEFULL_OBJECT160764STANDARDInpharmd_Response_PDF/Inpharmd_Response20250428-27684-cugfpt.pdf2025-04-28T13:50:46.000Z"5961c35fa9eaf5a23b5be1ae787983af"CRC64NVMEFULL_OBJECT137928STANDARDInpharmd_Response_PDF/Inpharmd_Response20250428-27684-j5egv3.pdf2025-04-28T13:26:52.000Z"4d022a5e712a7782baea24bd4281d9cb"CRC64NVMEFULL_OBJECT160764STANDARDInpharmd_Response_PDF/Inpharmd_Response20250428-27684-vyvhkd.pdf2025-04-28T13:30:40.000Z"bbbd9c8c49a0b5a8dd3b7094ffd6a45a"CRC64NVMEFULL_OBJECT151590STANDARDInpharmd_Response_PDF/Inpharmd_Response20250428-28238-zz2545.pdf2025-04-28T14:03:40.000Z"e8f55fc0c9435dd7d2d71039c1f6d1b7"CRC64NVMEFULL_OBJECT153690STANDARDInpharmd_Response_PDF/Inpharmd_Response20250428-28505-uv78uz.pdf2025-04-28T14:16:38.000Z"450cabff2872a2899e8e3759fb715d94"CRC64NVMEFULL_OBJECT155693STANDARDInpharmd_Response_PDF/Inpharmd_Response20250428-6-u3elc3.doc2025-04-28T11:54:14.000Z"5eafc6aa3020a117bb68b2685107d437"CRC64NVMEFULL_OBJECT186356STANDARDInpharmd_Response_PDF/Inpharmd_Response20250508-8-rpws8j.doc2025-05-08T11:51:14.000Z"05c5753796e18053de8874c7a7f0ce47"CRC64NVMEFULL_OBJECT180157STANDARDInpharmd_Response_PDF/Inpharmd_Response20250528-5-pjw56e.doc2025-05-28T12:56:49.000Z"7ca839b02332f8cc2cd3952c5368c6e7"CRC64NVMEFULL_OBJECT180540STANDARDInpharmd_Response_PDF/Inpharmd_Response20250528-8-pjw56e.doc2025-05-28T12:55:50.000Z"158ed45039907fc9cbebe2df5aa1a08c"CRC64NVMEFULL_OBJECT181496STANDARDInpharmd_Response_PDF/Inpharmd_Response20250609-70456-ii01i9.doc2025-06-09T14:22:15.000Z"0655486b6b3283b6ce2dfe7c1ba2e05b"CRC64NVMEFULL_OBJECT113605STANDARDInpharmd_Response_PDF/Inpharmd_Response20250609-8-p7bih.doc2025-06-09T12:15:15.000Z"88bd8833b9d6397f677aea1276499150"CRC64NVMEFULL_OBJECT179363STANDARDInpharmd_Response_PDF/Inpharmd_Response20250610-81601-c2s7ua.doc2025-06-10T14:26:15.000Z"a2cc71bfbbd111bfdd9a04dac16e37d4"CRC64NVMEFULL_OBJECT113833STANDARDInpharmd_Response_PDF/Inpharmd_Response20250611-96858-23iow8.doc2025-06-11T09:58:03.000Z"f9718f31bad9c7a01c196c8bbfddfec0"CRC64NVMEFULL_OBJECT113283STANDARDInpharmd_Response_PDF/Inpharmd_Response20250616-54953-9weqph.doc2025-06-16T15:05:35.000Z"96594cf6afee7d931c2d9319c6051677"CRC64NVMEFULL_OBJECT155985STANDARDInpharmd_Response_PDF/Inpharmd_Response20250618-5-avo8uc.doc2025-06-18T02:09:11.000Z"6b2ec746dc6118b7baea271afb1473dd"CRC64NVMEFULL_OBJECT141905STANDARDInpharmd_Response_PDF/Inpharmd_Response20250619-5-nm3zs2.doc2025-06-19T10:14:23.000Z"bd68a82a210033cb63c8d292ab752331"CRC64NVMEFULL_OBJECT140314STANDARDInpharmd_Response_PDF/Inpharmd_Response20250619-7-nm3zs2.doc2025-06-19T10:15:07.000Z"2ad05dbf6227881c5724fafd6b2057f0"CRC64NVMEFULL_OBJECT113307STANDARDInpharmd_Response_PDF/Inpharmd_Response20250624-168-ytv3wf.doc2025-06-24T06:20:13.000Z"0197c438c4881b668b0065052e633c72"CRC64NVMEFULL_OBJECT146930STANDARDInpharmd_Response_PDF/Inpharmd_Response20250625-78688-1iyc90.doc2025-06-25T05:21:48.000Z"67c222777e435c4045d5fac97d31fe75"CRC64NVMEFULL_OBJECT113777STANDARDInpharmd_Response_PDF/Inpharmd_Response20250625-8-akm5x1.doc2025-06-25T14:15:58.000Z"4ac9c2955a2162bafdf8228639e19928"CRC64NVMEFULL_OBJECT138868STANDARDInpharmd_Response_PDF/Inpharmd_Response20250627-5-ozsyxp.doc2025-06-27T06:20:23.000Z"823d3e205a61e75c2d7694c410bddde3"CRC64NVMEFULL_OBJECT145201STANDARDInpharmd_Response_PDF/Inpharmd_Response20250703-6439-1gj8ju.doc2025-07-03T07:01:01.000Z"1455ceb3a24c339ee020a06830bf585a"CRC64NVMEFULL_OBJECT140513STANDARDInpharmd_Response_PDF/Inpharmd_Response20250703-6439-q2n94o.doc2025-07-03T07:01:07.000Z"1455ceb3a24c339ee020a06830bf585a"CRC64NVMEFULL_OBJECT140513STANDARDInpharmd_Response_PDF/Inpharmd_Response20250703-6439-rcp6vl.doc2025-07-03T06:38:34.000Z"91cd372d4b79abaf20a7f2ad757a7c77"CRC64NVMEFULL_OBJECT142129STANDARDInpharmd_Response_PDF/Inpharmd_Response20250708-1942-8th6cq.doc2025-07-08T12:01:06.000Z"74f40feec7de143105a2945896084052"CRC64NVMEFULL_OBJECT113391STANDARDInpharmd_Response_PDF/Inpharmd_Response20250708-8-kfim14.doc2025-07-08T08:51:49.000Z"c4347848389ac15deced091eae058281"CRC64NVMEFULL_OBJECT179619STANDARDInpharmd_Response_PDF/Inpharmd_Response20250709-5-a640d3.doc2025-07-09T11:53:14.000Z"b1091505ae2e5cc06192ad1f2d3c1212"CRC64NVMEFULL_OBJECT142728STANDARDInpharmd_Response_PDF/Inpharmd_Response20250709-7-sxrwv1.doc2025-07-09T05:26:04.000Z"1a4af477e734e21c3b73792519c2557f"CRC64NVMEFULL_OBJECT183683STANDARDInpharmd_Response_PDF/Inpharmd_Response20250709-7-xue7dk.doc2025-07-09T13:43:31.000Z"fe7c256c8db67f90fc3ae5374a6d2f98"CRC64NVMEFULL_OBJECT179465STANDARDInpharmd_Response_PDF/Inpharmd_Response20250710-5-57oise.doc2025-07-10T14:21:24.000Z"7292726eacb6e649c519645f0fb3a09a"CRC64NVMEFULL_OBJECT180740STANDARDInpharmd_Response_PDF/Inpharmd_Response20250710-5-an17ns.doc2025-07-10T14:21:00.000Z"80fd4db6d2ba992edc30b1fbf350d360"CRC64NVMEFULL_OBJECT158490STANDARDInpharmd_Response_PDF/Inpharmd_Response20250710-8-28v2fg.doc2025-07-10T05:19:12.000Z"b6698659050d1183caf49ede54908393"CRC64NVMEFULL_OBJECT182911STANDARDInpharmd_Response_PDF/Inpharmd_Response20250710-8-tl0dll.doc2025-07-10T13:35:24.000Z"f32383e743905ddd8a7065883e916a3d"CRC64NVMEFULL_OBJECT179467STANDARDInpharmd_Response_PDF/Inpharmd_Response20250710-8-wpyywv.doc2025-07-10T14:37:42.000Z"c3cf2f69b09dc53ac510459b331fad4c"CRC64NVMEFULL_OBJECT139652STANDARDInpharmd_Response_PDF/Inpharmd_Response20250711-5-7pyt2t.doc2025-07-11T12:26:59.000Z"22f12ef0db4ed94295e1823b68e60f8d"CRC64NVMEFULL_OBJECT182533STANDARDInpharmd_Response_PDF/Inpharmd_Response20250711-5-8ideqg.doc2025-07-11T06:08:27.000Z"e28dd2615d7fdde27995b319ada765a8"CRC64NVMEFULL_OBJECT183492STANDARDInpharmd_Response_PDF/Inpharmd_Response20250711-5-mt0xlt.doc2025-07-11T05:50:55.000Z"d1cee25e11c9deeef194c76dda9ee5dd"CRC64NVMEFULL_OBJECT140982STANDARDInpharmd_Response_PDF/Inpharmd_Response20250714-8-jdhbk5.doc2025-07-14T07:22:36.000Z"1a0a6247186c6b2a8653c5822b0e489c"CRC64NVMEFULL_OBJECT154472STANDARDInpharmd_Response_PDF/Inpharmd_Response20250717-5-ei7cuk.doc2025-07-17T06:31:32.000Z"159379d2fd806f94cfe2e576a111348c"CRC64NVMEFULL_OBJECT139983STANDARDInpharmd_Response_PDF/Inpharmd_Response20250718-5-isylfi.doc2025-07-18T07:02:40.000Z"9b55d8ce92d8decc10e95ae71f36cf22"CRC64NVMEFULL_OBJECT139056STANDARDInpharmd_Response_PDF/Inpharmd_Response20250722-7-nbgydw.doc2025-07-22T08:43:50.000Z"cd0018c440d203dc4d349af863761df5"CRC64NVMEFULL_OBJECT137435STANDARDInpharmd_Response_PDF/Inpharmd_Response20250723-9-1rtla4.doc2025-07-23T09:16:53.000Z"b0faff66ba0150b52fb5cf48cf232cda"CRC64NVMEFULL_OBJECT153221STANDARDInpharmd_Response_PDF/Inpharmd_Response20250724-20-v274nt.doc2025-07-24T06:13:14.000Z"e1c112429bb56cb5514018ceda0f6818"CRC64NVMEFULL_OBJECT139894STANDARDInpharmd_Response_PDF/Inpharmd_Response20250724-50-35cgjv.doc2025-07-24T06:14:12.000Z"c59c665073079a7c4f7811efa6134ca3"CRC64NVMEFULL_OBJECT147399STANDARDInpharmd_Response_PDF/Inpharmd_Response20250728-9-hlkio4.doc2025-07-28T12:35:30.000Z"675ee0dd61c4ba7fb0701fc23ee88644"CRC64NVMEFULL_OBJECT157734STANDARDInpharmd_Response_PDF/Inpharmd_Response20250804-5-yt6kwx.doc2025-08-04T13:11:10.000Z"7308e099a39e6e1037f720469de1668a"CRC64NVMEFULL_OBJECT145140STANDARDInpharmd_Response_PDF/Inpharmd_Response20250804-5319-nx8evx.doc2025-08-04T05:40:10.000Z"167149b012eb3b6d6821eddbb6edf365"CRC64NVMEFULL_OBJECT124809STANDARDInpharmd_Response_PDF/Inpharmd_Response20250804-9302-u1rgr8.doc2025-08-04T11:35:05.000Z"07d252753132763ccea782ed0b51fd55"CRC64NVMEFULL_OBJECT114388STANDARDInpharmd_Response_PDF/Inpharmd_Response20250814-20-kpq128.doc2025-08-14T09:19:54.000Z"435278ef3a2e5f3ea0fc3c3caf59988e"CRC64NVMEFULL_OBJECT138148STANDARDInpharmd_Response_PDF/Inpharmd_Response20250819-8-yedprr.doc2025-08-19T08:59:07.000Z"2e62f922447cf648ac1ca2e216f59419"CRC64NVMEFULL_OBJECT139284STANDARDInpharmd_Response_PDF/Inpharmd_Response20250820-5-fvr4q7.doc2025-08-20T07:08:57.000Z"7dc8e54b2b99e652a39fc875314299db"CRC64NVMEFULL_OBJECT150806STANDARDInpharmd_Response_PDF/Inpharmd_Response20250820-8-5t3dif.doc2025-08-20T07:04:14.000Z"236d0b13d387b9e177bd740dd18adb49"CRC64NVMEFULL_OBJECT146055STANDARDInpharmd_Response_PDF/Inpharmd_Response20250821-5-s7jl4e.doc2025-08-21T07:28:01.000Z"bfd4481357bb8e4d2d2708402097b5b3"CRC64NVMEFULL_OBJECT154294STANDARDInpharmd_Response_PDF/Inpharmd_Response20250821-9-4xpu7u.doc2025-08-21T07:26:22.000Z"1505d7e2b02b8b1c50caa6af58a3748e"CRC64NVMEFULL_OBJECT142926STANDARDInpharmd_Response_PDF/Inpharmd_Response20250822-7-wnqyuz.doc2025-08-22T06:37:45.000Z"a8c5e196190ec126a2652a9a2333c27d"CRC64NVMEFULL_OBJECT138166STANDARDInpharmd_Response_PDF/Inpharmd_Response20250825-8-9r6vii.doc2025-08-25T06:40:14.000Z"ac17931abe1cb9dc1a8b29ecd40dab0f"CRC64NVMEFULL_OBJECT166956STANDARDInpharmd_Response_PDF/Inpharmd_Response20250901-5-34moep.doc2025-09-01T12:19:28.000Z"cd459f3473acbcbd7d66e20986b364ae"CRC64NVMEFULL_OBJECT150760STANDARDInpharmd_Response_PDF/Inpharmd_Response20250901-5-k6hfum.doc2025-09-01T12:20:08.000Z"6605a3858aaa635289d0ea94c18e485c"CRC64NVMEFULL_OBJECT143557STANDARDInpharmd_Response_PDF/Inpharmd_Response20250901-9-zqavn5.doc2025-09-01T12:19:27.000Z"c1c5b7aef13d895c13aa451c97a14488"CRC64NVMEFULL_OBJECT150761STANDARDInpharmd_Response_PDF/Inpharmd_Response20250903-44-bmw7sw.doc2025-09-03T00:20:40.000Z"412aa37bc003b46a5c367f005b77844f"CRC64NVMEFULL_OBJECT138143STANDARDInpharmd_Response_PDF/Inpharmd_Response20250903-5-6n8gty.doc2025-09-03T12:01:30.000Z"3ae57ee440687fe82aa9a601e62ab963"CRC64NVMEFULL_OBJECT117533STANDARDInpharmd_Response_PDF/Inpharmd_Response20250903-5-d5ktyq.doc2025-09-03T10:35:17.000Z"c637c41ee7b9f4443e7b262c28d33358"CRC64NVMEFULL_OBJECT188860STANDARDInpharmd_Response_PDF/Inpharmd_Response20250903-5-rtbpj2.doc2025-09-03T00:19:32.000Z"bbf1d4167c9730d60198d1d7f483caa2"CRC64NVMEFULL_OBJECT156230STANDARDInpharmd_Response_PDF/Inpharmd_Response20250903-5-wwdu0o.doc2025-09-03T09:19:27.000Z"59392a7b63e7b0b81edd67267a1d7cf2"CRC64NVMEFULL_OBJECT178794STANDARDInpharmd_Response_PDF/Inpharmd_Response20250903-7-74ka5b.doc2025-09-03T12:02:28.000Z"d679ceb4c890566ee651c307d76676e6"CRC64NVMEFULL_OBJECT145424STANDARDInpharmd_Response_PDF/Inpharmd_Response20250903-7-ychfea.doc2025-09-03T07:35:55.000Z"48ab61996078d185604caba2e55bdbb3"CRC64NVMEFULL_OBJECT181284STANDARDInpharmd_Response_PDF/Inpharmd_Response20250909-9-29yrr9.doc2025-09-09T05:56:09.000Z"29e1125433453674f50fafab7e07bbea"CRC64NVMEFULL_OBJECT136930STANDARDInpharmd_Response_PDF/Inpharmd_Response20250915-7-n7am95.doc2025-09-15T08:42:47.000Z"bbf491cf6e977cbeb706a0d2b4ff7788"CRC64NVMEFULL_OBJECT142192STANDARDInpharmd_Response_PDF/Inpharmd_Response20250915-9-dwb8fz.doc2025-09-15T08:49:27.000Z"74ba964f1e5f7f29da36f3745a65ffa0"CRC64NVMEFULL_OBJECT145856STANDARDInpharmd_Response_PDF/Inpharmd_Response20250918-5-qrp1g1.doc2025-09-18T08:58:33.000Z"5d9f5a12bdad4d07b2567d1450a38e54"CRC64NVMEFULL_OBJECT146816STANDARDInpharmd_Response_PDF/Inpharmd_Response20250918-7-e1cmto.doc2025-09-18T15:13:24.000Z"d077b7d929f4ceab500f1fd531c6683b"CRC64NVMEFULL_OBJECT142411STANDARDInpharmd_Response_PDF/Inpharmd_Response20250919-7-fi5pte.doc2025-09-19T07:24:16.000Z"757eb6a58823435fe1f4500064014350"CRC64NVMEFULL_OBJECT143906STANDARDInpharmd_Response_PDF/Inpharmd_Response20250922-45-304ynz.doc2025-09-22T09:09:21.000Z"f1a4195f633131d785404c60fcbb6231"CRC64NVMEFULL_OBJECT143672STANDARDInpharmd_Response_PDF/Inpharmd_Response20250929-7-nh2hys.doc2025-09-29T13:11:31.000Z"697c094c26b50d1a91bc69a2e6efd755"CRC64NVMEFULL_OBJECT138303STANDARDInpharmd_Response_PDF/Inpharmd_Response20250930-7-8qgii0.doc2025-09-30T06:07:17.000Z"2a3b7c9668fd4ae4ded3d9decc4e557c"CRC64NVMEFULL_OBJECT141274STANDARDInpharmd_Response_PDF/Inpharmd_Response20251006-5-nb3psa.doc2025-10-06T10:14:03.000Z"9d27a0ea576f153e87d4239e7c9b5487"CRC64NVMEFULL_OBJECT139035STANDARDInpharmd_Response_PDF/Inpharmd_Response20251006-7-4w7dde.doc2025-10-06T10:27:02.000Z"a6ed643ea5f88faa2a478633ad2a6495"CRC64NVMEFULL_OBJECT137277STANDARDInpharmd_Response_PDF/Inpharmd_Response20251007-5-i89ss.doc2025-10-07T10:28:54.000Z"f22c5849ee6616afac314d2f96dd2350"CRC64NVMEFULL_OBJECT138023STANDARDInpharmd_Response_PDF/Inpharmd_Response20251009-5-h6cg9.doc2025-10-09T06:46:35.000Z"10cb5c4fbe47c5dfca3a9b46d8968cac"CRC64NVMEFULL_OBJECT143961STANDARDInpharmd_Response_PDF/Inpharmd_Response20251014-7-wdp379.doc2025-10-14T09:19:02.000Z"f0886a5e6939a1030c6db4240a94ec52"CRC64NVMEFULL_OBJECT140306STANDARDInpharmd_Response_PDF/Inpharmd_Response20251014-8-kqis0y.doc2025-10-14T09:08:21.000Z"c609c4c516398a25de6b65af8a11e522"CRC64NVMEFULL_OBJECT147277STANDARDInpharmd_Response_PDF/Inpharmd_Response20251018-7-z1udz4.doc2025-10-18T14:03:24.000Z"5a738739eab698de892bb8ea40a13076"CRC64NVMEFULL_OBJECT143074STANDARDInpharmd_Response_PDF/Inpharmd_Response20251022-154-s2xv0x.doc2025-10-22T08:49:46.000Z"ac7983ca9b475d50e44f9bdde84d2b05"CRC64NVMEFULL_OBJECT139232STANDARDInpharmd_Response_PDF/Inpharmd_Response20251029-5-pz0eh9.doc2025-10-29T12:55:12.000Z"f2281ea02f0431b4773d0f7ee2393918"CRC64NVMEFULL_OBJECT117191STANDARDInpharmd_Response_PDF/Inpharmd_Response20251030-5-tielbw.doc2025-10-30T09:40:14.000Z"792e372276cb04bc6f7e2c0a7aada037"CRC64NVMEFULL_OBJECT139359STANDARDInpharmd_Response_PDF/Inpharmd_Response20251030-8-u2c42m.doc2025-10-30T09:39:08.000Z"d37ca3c94458bcb0f6ff19bec161d587"CRC64NVMEFULL_OBJECT137172STANDARDInpharmd_Response_PDF/Inpharmd_Response20251031-7-jh0kx6.doc2025-10-31T09:24:17.000Z"338b6db3389950545998b6d4caffb1c9"CRC64NVMEFULL_OBJECT158684STANDARDInpharmd_Response_PDF/Inpharmd_Response20251105-5-4ekze5.doc2025-11-05T10:05:00.000Z"1704d82d161e6c6ce2c63feea0ac12eb"CRC64NVMEFULL_OBJECT137791STANDARDInpharmd_Response_PDF/Inpharmd_Response20251110-7-mp2i1o.doc2025-11-10T10:10:23.000Z"ba3282806430ea1b3d62446f5199faa0"CRC64NVMEFULL_OBJECT139663STANDARDInpharmd_Response_PDF/Inpharmd_Response20251110-7-ve639z.doc2025-11-10T10:09:56.000Z"85743dde8e62d7facb3b57c4bf0b7486"CRC64NVMEFULL_OBJECT138476STANDARDInpharmd_Response_PDF/Inpharmd_Response20251111-7-3ws3cu.doc2025-11-11T06:01:05.000Z"f4237b3113c5f1169068c92f7831d70a"CRC64NVMEFULL_OBJECT137798STANDARDInpharmd_Response_PDF/Inpharmd_Response20251121-7-jpfueb.doc2025-11-21T06:32:35.000Z"ab7926b7eb58fff4e533181d2b1363e5"CRC64NVMEFULL_OBJECT146794STANDARDInpharmd_Response_PDF/Inpharmd_Response20251126-5-457eix.doc2025-11-26T13:16:15.000Z"1dc2623fc6ddf4b6b3e79e63a57992d7"CRC64NVMEFULL_OBJECT142891STANDARDInpharmd_Response_PDF/Inpharmd_Response20251203-5-b71j17.doc2025-12-03T06:50:48.000Z"5aa4dc23f5bdf3da4748bd7637c6ed8a"CRC64NVMEFULL_OBJECT138271STANDARDInpharmd_Response_PDF/Inpharmd_Response20251205-7-228bc0.doc2025-12-05T11:51:00.000Z"3e193d263e760badc3b1590676335fec"CRC64NVMEFULL_OBJECT157201STANDARDInpharmd_Response_PDF/Inpharmd_Response20251212-5-6ceh0g.doc2025-12-12T05:48:26.000Z"5f17f2713d31c1bc2d6e77010ca9df44"CRC64NVMEFULL_OBJECT142393STANDARDInpharmd_Response_PDF/Inpharmd_Response20251215-5-666z4w.doc2025-12-15T19:00:10.000Z"7c2be0e08460bb3cd84e5c750d3a8186"CRC64NVMEFULL_OBJECT183408STANDARDInpharmd_Response_PDF/Inpharmd_Response20251215-5-d7qg75.doc2025-12-15T19:03:31.000Z"3d7331155a498ad191a024a331ceb802"CRC64NVMEFULL_OBJECT179169STANDARDInpharmd_Response_PDF/Inpharmd_Response20251215-6-i47l1f.doc2025-12-15T18:22:29.000Z"a816b4b898620ba844bba359b7d2ac20"CRC64NVMEFULL_OBJECT182613STANDARDInpharmd_Response_PDF/Inpharmd_Response20251215-7-666z4w.doc2025-12-15T18:59:46.000Z"afd8157fce4a59a729ea422c25b70edc"CRC64NVMEFULL_OBJECT180651STANDARDInpharmd_Response_PDF/Inpharmd_Response20251215-7-t2or7g.doc2025-12-15T18:57:20.000Z"285dd3d628181ab10003e9deb6ecf42b"CRC64NVMEFULL_OBJECT195563STANDARDInpharmd_Response_PDF/Inpharmd_Response20251215-7-v6rc10.doc2025-12-15T18:47:44.000Z"51debb10165fc769a85748d3a7e2baad"CRC64NVMEFULL_OBJECT159324STANDARDInpharmd_Response_PDF/Inpharmd_Response20251216-5-2bahtx.doc2025-12-16T12:31:39.000Z"3f5530c431cb8f7576419e02ca19212a"CRC64NVMEFULL_OBJECT140203STANDARDInpharmd_Response_PDF/Inpharmd_Response20251216-5-zvlhw9.doc2025-12-16T05:43:33.000Z"6d42ccce7c3f4678b0df307373bf7a92"CRC64NVMEFULL_OBJECT183424STANDARDInpharmd_Response_PDF/Inpharmd_Response20251216-5-zzx7kk.doc2025-12-16T05:45:08.000Z"02e68ba0b6f68f3be073857b66cd062c"CRC64NVMEFULL_OBJECT180134STANDARDInpharmd_Response_PDF/Inpharmd_Response20251216-7-hhvzu1.doc2025-12-16T05:45:43.000Z"1567af3ad282c6da63671d8388a16018"CRC64NVMEFULL_OBJECT183372STANDARDInpharmd_Response_PDF/Inpharmd_Response20251216-7-u0cizp.doc2025-12-16T06:22:46.000Z"951070dbb0f86c073af39800eb4cb253"CRC64NVMEFULL_OBJECT182609STANDARDInpharmd_Response_PDF/Inpharmd_Response20251216-8-hhvzu1.doc2025-12-16T05:42:19.000Z"71bfa95fcfb0ed60737e9b5283bf9c7a"CRC64NVMEFULL_OBJECT182651STANDARDInpharmd_Response_PDF/Inpharmd_Response20251216-9-dgw57e.doc2025-12-16T12:21:20.000Z"a800de286351d09c24451d59de2dd375"CRC64NVMEFULL_OBJECT182957STANDARDInpharmd_Response_PDF/Inpharmd_Response20251218-7-zonriq.doc2025-12-18T07:10:36.000Z"8ad00ca5d8cff3e21267738928b1ccd7"CRC64NVMEFULL_OBJECT138704STANDARDInpharmd_Response_PDF/Inpharmd_Response20251219-5-xlrxr7.doc2025-12-19T07:00:43.000Z"d8c8bcaebe0b300b1504ea38952f475c"CRC64NVMEFULL_OBJECT139671STANDARDInpharmd_Response_PDF/Inpharmd_Response20251222-7-qtqf6y.doc2025-12-22T11:12:19.000Z"8d8d5a4d40462165946ee6b1104592b0"CRC64NVMEFULL_OBJECT144194STANDARDInpharmd_Response_PDF/Inpharmd_Response20251222-8-pfjc9q.doc2025-12-22T11:11:47.000Z"36ce7bdf0e7f1d01dba50759108b6ee6"CRC64NVMEFULL_OBJECT143548STANDARDInpharmd_Response_PDF/Inpharmd_Response20251223-5-r2dafi.doc2025-12-23T09:24:00.000Z"14bb9aad59488ec1dc49c530d64a6b23"CRC64NVMEFULL_OBJECT140458STANDARDInpharmd_Response_PDF/Inpharmd_Response20251229-7-a32va7.doc2025-12-29T23:05:33.000Z"5f286096a83b07d33c3c75ea9feac10d"CRC64NVMEFULL_OBJECT158795STANDARDInpharmd_Response_PDF/Inpharmd_Response20251230-7-o90ajq.doc2025-12-30T11:06:43.000Z"07a9ef5f1cc009cd1dd9b4ddd3ae10ce"CRC64NVMEFULL_OBJECT181944STANDARDInpharmd_Response_PDF/Inpharmd_Response20260102-22-oj9axr.doc2026-01-02T05:24:35.000Z"ac1c2cb9c1ab1ef46adaad1b4135d24f"CRC64NVMEFULL_OBJECT160396STANDARDInpharmd_Response_PDF/Inpharmd_Response20260109-5-23zdvz.doc2026-01-09T11:36:52.000Z"b70f2f43a490141ed8d6953f7550ef94"CRC64NVMEFULL_OBJECT195556STANDARDInpharmd_Response_PDF/Inpharmd_Response20260109-8-7hbgd7.doc2026-01-09T09:05:50.000Z"5c6689b4bfbf70074f436a294b1aa832"CRC64NVMEFULL_OBJECT157997STANDARDInpharmd_Response_PDF/Inpharmd_Response20260109-8-bag3vp.doc2026-01-09T08:55:09.000Z"527b0553c3f689f910b24220b29207ae"CRC64NVMEFULL_OBJECT158279STANDARDInpharmd_Response_PDF/Inpharmd_Response20260109-9-k0ml6n.doc2026-01-09T12:09:38.000Z"334e94039ea542de451ee6f379755e68"CRC64NVMEFULL_OBJECT181396STANDARDInpharmd_Response_PDF/Inpharmd_Response20260120-9-kh7xwu.doc2026-01-20T07:20:51.000Z"4ea75f449f5a80b6e26806242159d398"CRC64NVMEFULL_OBJECT144076STANDARDInpharmd_Response_PDF/Inpharmd_Response20260121-7-it6gd3.doc2026-01-21T07:08:46.000Z"0b197f9e2c946f4138314018f98b5bed"CRC64NVMEFULL_OBJECT181339STANDARDInpharmd_Response_PDF/Inpharmd_Response20260122-5-psai2y.doc2026-01-22T12:09:03.000Z"eedb4a53c77de30be8030ed6b09836ca"CRC64NVMEFULL_OBJECT183716STANDARDInpharmd_Response_PDF/Inpharmd_Response20260122-7-1j54yx.doc2026-01-22T09:09:05.000Z"90fdcb0a9d6a81a2289f18e770b905f6"CRC64NVMEFULL_OBJECT179161STANDARDInpharmd_Response_PDF/Inpharmd_Response20260212-5-jrudgf.doc2026-02-12T07:11:31.000Z"af8a6f96e93ab8b2421370d50661a4c6"CRC64NVMEFULL_OBJECT146536STANDARDInpharmd_Response_PDF/Inpharmd_Response20260212-9-1tsyey.doc2026-02-12T07:10:15.000Z"7ae0828d283dbc4a9aadd92be17e57ad"CRC64NVMEFULL_OBJECT120082STANDARDInpharmd_Response_PDF/Inpharmd_Response20260217-5-8w4rbr.doc2026-02-17T05:28:00.000Z"62ead5e9c9cf38e5b668396b535de7fe"CRC64NVMEFULL_OBJECT181487STANDARDInpharmd_Response_PDF/Inpharmd_Response20260225-5-ghof3h.doc2026-02-25T11:14:36.000Z"8f68110d4959de2b7492d62984cb3637"CRC64NVMEFULL_OBJECT157684STANDARDInpharmd_Response_PDF/Inpharmd_Response20260225-8-qeeykm.doc2026-02-25T11:48:34.000Z"f8d305baf6f4fb437db338490d9bb7c9"CRC64NVMEFULL_OBJECT181026STANDARDInpharmd_Response_PDF/Inpharmd_Response20260227-5-6jttwv.doc2026-02-27T10:12:31.000Z"acd6070e94a06776a77c10419082101f"CRC64NVMEFULL_OBJECT184379STANDARDInpharmd_Response_PDF/Inpharmd_Response20260302-7-r8z2ms.doc2026-03-02T13:26:04.000Z"fabc41d21d3fe036302a814113b7101a"CRC64NVMEFULL_OBJECT157410STANDARDInpharmd_Response_PDF/Inpharmd_Response20260306-85-znvrcv.doc2026-03-06T11:29:22.000Z"808f27ca1b8e1c1cb2c5bfeb95a95dcb"CRC64NVMEFULL_OBJECT181489STANDARDInpharmd_Response_PDF/Inpharmd_Response20260317-5-wnfh75.doc2026-03-17T09:58:31.000Z"1fbdbaa483471c6743ee8434d86b63e8"CRC64NVMEFULL_OBJECT145214STANDARDInpharmd_Response_PDF/Summary_Jemperli20251014-2848-mw5zih.pdf2025-10-14T09:20:46.000Z"25bf1864fc96badefc33ab1471d7d2cd"CRC64NVMEFULL_OBJECT382279STANDARDInpharmd_Response_PDF/certificate20251014-8427-1yf337.pdf2025-10-14T10:34:26.000Z"f65a3bcf848f17043e58f5c5536cb9e0"CRC64NVMEFULL_OBJECT425948STANDARDInpharmd_Response_PDF/coverage_library1220251014-8427-v4gaml.pdf2025-10-14T10:15:18.000Z"c7a7165d0c3265d7f67a6927ddb395d0"CRC64NVMEFULL_OBJECT160516STANDARDInpharmd_Response_PDF/coverage_library220251014-2848-pva2al.pdf2025-10-14T09:25:35.000Z"c4e761de0d4951c7d0f359fdf6be9ad9"CRC64NVMEFULL_OBJECT52779STANDARDInpharmd_Response_PDF/drug_stability120251014-8427-mingk7.pdf2025-10-14T10:09:26.000Z"57ee757b348f8f84a6a8bff10a1f94ac"CRC64NVMEFULL_OBJECT89996STANDARDNew Inpharmd/2024-04-18T14:58:35.000Z"d41d8cd98f00b204e9800998ecf8427e"0STANDARDNew Inpharmd/Baycare.svg2024-04-18T14:59:51.000Z"47fde49f89484522af4c73c5839de7e3"23978STANDARDNew Inpharmd/Bon Secours Mercy Health.svg2024-04-18T14:59:49.000Z"f96f3dc49cf101bf08504127d957de16"20517STANDARDNew Inpharmd/DPH.svg2024-04-18T14:59:46.000Z"7aa05edf2362fd1f0f0f9a00a4c83700"21782STANDARDNew Inpharmd/Dartmouth Hitchcock.svg2024-04-18T14:59:48.000Z"8fbe891108d88a3ff159711472e6208a"49660STANDARDNew Inpharmd/ECU Health.svg2024-04-18T14:59:45.000Z"ce883cf76fe70be22c01c1cd308f7ec5"23131STANDARDNew Inpharmd/Emory.svg2024-04-19T10:28:51.000Z"a05453f0d69d50c447a93beeaf17f1f6"52053STANDARDNew Inpharmd/Kettering.svg2024-04-18T14:59:43.000Z"3248cabc0472ef489191962e9e3076b1"10439STANDARDNew Inpharmd/Legacy Health.svg2024-04-18T14:59:42.000Z"d2fba09805330696f6bda9bbf83d9bc2"45311STANDARDNew Inpharmd/Life Point Health.svg2024-04-18T14:59:41.000Z"3f110c942f6e432fe88d284b31942a40"43564STANDARDNew Inpharmd/Medstar Health.svg2024-04-18T14:59:39.000Z"170d1b6627e142504675aceb67ba67ed"21903STANDARDNew Inpharmd/Mount Sinai.svg2024-04-18T14:59:38.000Z"3734506ed37c60eb239078dbb27fb757"80340STANDARDNew Inpharmd/Multicare.svg2024-04-19T10:28:52.000Z"d6b09c029ff46db933f2f57b20cb7078"19857STANDARDNew Inpharmd/Oregon Health Science University.svg2024-04-18T14:59:37.000Z"b841979452470ce930fa1be53a28b5c7"49382STANDARDNew Inpharmd/Piedmont.svg2024-04-18T14:59:35.000Z"252518f2a23a4e5f468fc617136b4d24"16392STANDARDNew Inpharmd/Riverside.svg2024-04-18T14:59:34.000Z"2e21c7a1a832021c367544e23d06b095"24214STANDARDNew Inpharmd/Saint Francis.svg2024-04-18T14:59:33.000Z"415d416ab8358355fe8af9881ea2a79e"20668STANDARDNew Inpharmd/St. Charles Health System.svg2024-04-18T14:59:32.000Z"de01ef85fb5476725ff61d33044d07fb"55010STANDARDNew Inpharmd/Sutter Health.svg2024-04-18T14:59:30.000Z"e77406c31a86263ab7d8d35261a3cefb"34740STANDARDNew Inpharmd/UC Davis Health.svg2024-04-18T14:59:29.000Z"bb223ee25b4756a5ded2b6ad4b2eeee3"28553STANDARDNew Inpharmd/UTMB.svg2024-04-18T14:59:26.000Z"607a638289ec81c69867eecaeb585c4d"11175STANDARDNew Inpharmd/University of Maryland.svg2024-04-18T14:59:28.000Z"bbdfcd94c25d173c0c675fb72e7477f6"81730STANDARDNew Inpharmd/Vizient.svg2024-04-18T14:59:25.000Z"b7997fe25fb05ed2a21186ee77d6688d"47159STANDARDNew Inpharmd/Wellstar.svg2024-04-18T14:59:24.000Z"751a688454df0795e6ea5a8031c2f1c8"18922STANDARDNew Inpharmd/Yale New Haven Health.svg2024-04-18T14:59:22.000Z"1818834fb4a3954ad42935772b0f7206"6045STANDARDRackMultipart20231120-26691-dnlhin.png2023-11-20T09:46:18.000Z"2852b98f1a492585d7265fd3dffc9176"7917796c5c1d53fd60f031dd1209b98518b7851853a07a3841337551b7a81621f391f3STANDARDRackMultipart20240103-11955-1tpqdru.png2024-01-03T10:07:14.000Z"daba8b7bf267149279fae12cee2ae91b"130388STANDARDRackMultipart20240103-12351-1bi41un.png2024-01-03T10:13:19.000Z"daba8b7bf267149279fae12cee2ae91b"130388STANDARDRackMultipart20240103-12918-9tzsml.png2024-01-03T10:16:55.000Z"daba8b7bf267149279fae12cee2ae91b"130388STANDARDZevtera.png2024-04-11T16:23:37.000Z"4f4948db622bf72da9c08b8efed0614b"227064STANDARDblog_images/Blog 1.png2024-01-31T15:50:48.000Z"f02d409413a6d99029900d3dcf572d44"40668STANDARDblog_images/Doxy_blog_1.png2024-01-31T16:49:22.000Z"ecfb5885a6fc3ceb295fdc4d6bc6fcfc"130448STANDARDblog_images/Doxy_blog_2.png2024-01-31T16:50:38.000Z"a4d74898578598163505408cc4ade4c9"100011STANDARDblog_images/Doxy_blog_3.png2024-01-31T16:51:25.000Z"077c33d4889cfe794cf9249955cad73f"116593STANDARDblog_images/Doxy_blog_4.png2024-01-31T16:52:25.000Z"2aae90a5b475effd987c1145c6dcb314"135918STANDARDblog_images/Doxy_blog_5.png2024-01-31T16:53:08.000Z"3363136dc1ce601e350433c920cf2cbd"204002STANDARDblog_images/Doxy_blog_6.png2024-01-31T16:53:52.000Z"614a806986efed748a4a3433b34c1828"169255STANDARDblog_images/Doxy_blog_7.png2024-01-31T16:55:41.000Z"dd887dd20c8b31da9cef953f65093812"385610STANDARDblog_images/EBM.png2023-12-23T06:35:06.000Z"86fca97d3c5ec4441be288b7b117ba09"379444STANDARDblog_images/Engineering_Blog_Image_1.png2023-11-27T09:21:36.000Z"9b96c5ecc66958c7d91a188ee8ac29de"36074STANDARDblog_images/Engineering_Blog_Image_3.png2023-11-27T09:22:08.000Z"44f0487ec1cae2a4303db7416a92e4bf"88092STANDARDblog_images/Engineering_Blog_Image_4.png2023-11-29T09:35:23.000Z"dbf02b0d42f9434b19f2c0d5826065d4"74705STANDARDblog_images/Engineering_Blog_Image_5.png2023-11-29T09:36:03.000Z"b83f9ac7b81a21649662b273045771b9"42166STANDARDblog_images/Engineering_Blog_Image_6.png2023-11-29T09:49:01.000Z"c90165944b5788f137b521f82424113a"11526STANDARDblog_images/Inpharmd CE.png2023-12-23T06:35:40.000Z"b1d0bb814d73fa4e2ea8f2e7e17e8113"635158STANDARDblog_images/Inpharmd Graph.png2023-11-22T15:57:44.000Z"00b68c80f0fdc3f159f694fd6aa9123c"38040STANDARDblog_images/Inpharmd_Blog_1.gif2023-11-27T09:23:43.000Z"2894794dfc213783cd5131617f5e5bc9"851627STANDARDblog_images/Inpharmd_Blog_2.gif2023-11-27T09:24:13.000Z"49a882bf5887f7b58ec9bfd2807ee1b0"3586074STANDARDblog_images/MMsticker.png2023-12-05T16:43:58.000Z"0500a69af9ec75aa5ef44ca1c7a444eb"1364808STANDARDblog_images/ai_demo2.gif2024-01-13T20:37:53.000Z"34ad347ffd48a38167c1c7788b36aed6-3"45300878STANDARDblog_images/dollar_100.jpg2023-12-09T19:12:02.000Z"9e64b0f184509e20163f896128e49813"4998226c5c1d53fd60f031dd1209b98518b7851853a07a3841337551b7a81621f391f3STANDARDblog_images/images/000/000/001/medium/IMG_2629.JPG2018-03-03T01:21:57.000Z"0498ee081bf1d1836463eb633bca12f9"42257STANDARDblog_images/images/000/000/001/original/IMG_2629.JPG2018-03-03T01:21:56.000Z"a2c27c72536b7bff8a6760a8d3a24a35"1422143STANDARDblog_images/images/000/000/001/small/IMG_2629.JPG2018-03-03T01:21:57.000Z"940396460873e4624c2abf949d20330e"8196STANDARDblog_images/images/000/000/001/thumb/IMG_2629.JPG2018-03-03T01:21:57.000Z"a33cc0d51509036f27ac8f918fd18af0"1235STANDARDblog_images/images/000/000/002/medium/inpharm3.jpeg2020-01-25T10:35:36.000Z"af93afb610a90be648bd3df499b1c593"8367STANDARDblog_images/images/000/000/002/original/inpharm3.jpeg2020-01-25T10:35:36.000Z"ad7ed291faf5a133629d01e0fc908759"7636STANDARDblog_images/images/000/000/002/small/inpharm3.jpeg2020-01-25T10:35:36.000Z"72b4c931f3271ae9685cec1f031c23ab"7029STANDARDblog_images/images/000/000/002/thumb/inpharm3.jpeg2020-01-25T10:35:36.000Z"71893a989812d83a1b9b8f32ec6a4600"4722STANDARDblog_images/images/000/000/003/medium/Asset_5.png2020-01-31T13:26:33.000Z"55cb2919a4b39c7bf0b9607cd952cc3d"2372STANDARDblog_images/images/000/000/003/original/Asset_5.png2020-01-31T13:26:33.000Z"e354df423cf5aa63227ad1b79036516c"5153STANDARDblog_images/images/000/000/003/small/Asset_5.png2020-01-31T13:26:33.000Z"55cb2919a4b39c7bf0b9607cd952cc3d"2372STANDARDblog_images/images/000/000/003/thumb/Asset_5.png2020-01-31T13:26:33.000Z"55cb2919a4b39c7bf0b9607cd952cc3d"2372STANDARDblog_images/images/000/000/004/medium/Asset_31_4x.png2020-01-31T13:46:59.000Z"f608b90cd96aae0ff0c59bd624cd4127"37748STANDARDblog_images/images/000/000/004/original/Asset_31_4x.png2020-01-31T13:46:59.000Z"f79f021751db7e88e23af86a78323386"19536STANDARDblog_images/images/000/000/004/small/Asset_31_4x.png2020-01-31T13:46:59.000Z"49174b3564b893d60e8610a40757190a"14155STANDARDblog_images/images/000/000/004/thumb/Asset_31_4x.png2020-01-31T13:46:59.000Z"960644b332b91b5c893f5e5696f74642"10470STANDARDblog_images/images/000/000/005/medium/Asset_32_4x.png2020-01-31T13:47:12.000Z"7674cd1679de6ef8746d4874f072d77d"37552STANDARDblog_images/images/000/000/005/original/Asset_32_4x.png2020-01-31T13:47:12.000Z"3c1d068059eb3f28ed3f66465e8ca289"18196STANDARDblog_images/images/000/000/005/small/Asset_32_4x.png2020-01-31T13:47:12.000Z"38736ae265c21597e5fec5e83f1f1087"11863STANDARDblog_images/images/000/000/005/thumb/Asset_32_4x.png2020-01-31T13:47:12.000Z"55d36bd6927a2b380337b7f98445108d"8643STANDARDblog_images/images/000/000/006/medium/Asset_30_4x.png2020-01-31T13:47:24.000Z"ac3c7eccd5f2f15cdbdf430e5835dc21"48224STANDARDblog_images/images/000/000/006/original/Asset_30_4x.png2020-01-31T13:47:23.000Z"264c143ff2f7ca84222a02ce98b9d61c"26818STANDARDblog_images/images/000/000/006/small/Asset_30_4x.png2020-01-31T13:47:24.000Z"c3100dd541d7e0e0807650c943093e98"16753STANDARDblog_images/images/000/000/006/thumb/Asset_30_4x.png2020-01-31T13:47:23.000Z"982bc324336816522f1459dfb2417255"12016STANDARDblog_images/images/000/000/007/medium/Asset_17_4x.png2020-03-17T18:18:32.000Z"06c1d76faf889b5b12fcf8dbe05eed2c"25055STANDARDblog_images/images/000/000/007/original/Asset_17_4x.png2020-03-17T18:18:32.000Z"b78be1011c8cf668b6b754c461beb089"14186STANDARDblog_images/images/000/000/007/small/Asset_17_4x.png2020-03-17T18:18:32.000Z"e83ea4fd99a9022b97418d287c55bfba"9729STANDARDblog_images/images/000/000/007/thumb/Asset_17_4x.png2020-03-17T18:18:32.000Z"6fe53eff241803856a6d5a48bb2b0bb7"7280STANDARDblog_images/images/000/000/008/medium/Asset_17_4x.png2020-03-17T18:18:41.000Z"c257e1f6bdc3c497c05be504935c14c2"25055STANDARDblog_images/images/000/000/008/original/Asset_17_4x.png2020-03-17T18:18:40.000Z"b78be1011c8cf668b6b754c461beb089"14186STANDARDblog_images/images/000/000/008/small/Asset_17_4x.png2020-03-17T18:18:41.000Z"68ab464cf1ef9625d6783952c87f8b3e"9729STANDARDblog_images/images/000/000/008/thumb/Asset_17_4x.png2020-03-17T18:18:41.000Z"6ff3d4bdb1ac056b833ab900a18d8090"7280STANDARDblog_images/images/000/000/009/medium/Asset_17_4x.png2020-03-17T18:18:49.000Z"da36357c00a6fb6561893b00a854abe0"25055STANDARDblog_images/images/000/000/009/original/Asset_17_4x.png2020-03-17T18:18:49.000Z"b78be1011c8cf668b6b754c461beb089"14186STANDARDblog_images/images/000/000/009/small/Asset_17_4x.png2020-03-17T18:18:49.000Z"5bca47417e62f9d224ea02ceb3440e9f"9729STANDARDblog_images/images/000/000/009/thumb/Asset_17_4x.png2020-03-17T18:18:49.000Z"dd30defe47ec322fb41f05001bd4ec53"7280STANDARDblog_images/images/000/000/010/medium/Asset_43_4x.png2020-11-21T16:22:59.000Z"f17973b8309abb987902783245a29882"28104STANDARDblog_images/images/000/000/010/original/Asset_43_4x.png2020-11-21T16:22:59.000Z"75d89875b4f4c2b9a73b3383f4662d4c"14873STANDARDblog_images/images/000/000/010/small/Asset_43_4x.png2020-11-21T16:22:59.000Z"114b733ce81a804c71c5a24e659f7ff5"10455STANDARDblog_images/images/000/000/010/thumb/Asset_43_4x.png2020-11-21T16:22:59.000Z"c7fab57b057eaacc60c2b4ae8b299bf7"7670STANDARDblog_images/images/000/000/011/medium/Asset_40_4x.png2020-11-21T16:23:13.000Z"bab1e394d71fa9987f93dd6f246f8881"30808STANDARDblog_images/images/000/000/011/original/Asset_40_4x.png2020-11-21T16:23:13.000Z"bdf2057a5054ba7b5a0e81dceacf25d4"21481STANDARDblog_images/images/000/000/011/small/Asset_40_4x.png2020-11-21T16:23:13.000Z"ea350ffce4252ecc484d200c13dd5105"11801STANDARDblog_images/images/000/000/011/thumb/Asset_40_4x.png2020-11-21T16:23:13.000Z"c15ca9a9a53e848e97bc77f11750c0d6"8777STANDARDblog_images/images/000/000/012/medium/Asset_39_4x.png2020-11-21T16:23:26.000Z"aaeac70a8f62d347392109f62790149a"12336STANDARDblog_images/images/000/000/012/original/Asset_39_4x.png2020-11-21T16:23:25.000Z"e8e35f6e31ddb70341b486a0da07d83b"10479STANDARDblog_images/images/000/000/012/small/Asset_39_4x.png2020-11-21T16:23:26.000Z"0209666fcf1c1fffe49ce59ebe2548be"5042STANDARDblog_images/images/000/000/012/thumb/Asset_39_4x.png2020-11-21T16:23:26.000Z"4a14d5709cce198aaaa1bcd71cc8de20"3897STANDARDblog_images/images/000/000/013/medium/Asset_14_4x.png2021-04-08T14:28:12.000Z"52932c1b1970f1e17cc2a9f9da8c870a"25493STANDARDblog_images/images/000/000/013/original/Asset_14_4x.png2021-04-08T14:28:12.000Z"636cee934a46dc1b4d3c654ee0f85463"14612STANDARDblog_images/images/000/000/013/small/Asset_14_4x.png2021-04-08T14:28:12.000Z"74e16877816144d12fb010c759e17e7b"9879STANDARDblog_images/images/000/000/013/thumb/Asset_14_4x.png2021-04-08T14:28:12.000Z"2b2c2b40908de6eab9dc37c65daf48ea"7253STANDARDblog_images/images/000/000/014/medium/Asset_15_4x.png2021-04-08T14:28:55.000Z"ce3c43e325f7d7aa88de86a031a19998"39760STANDARDblog_images/images/000/000/014/original/Asset_15_4x.png2021-04-08T14:28:55.000Z"f45ee58fb47f7961c96d08db0c4e079a"19982STANDARDblog_images/images/000/000/014/small/Asset_15_4x.png2021-04-08T14:28:55.000Z"8ed52981c9445952db41cd18435349e0"14294STANDARDblog_images/images/000/000/014/thumb/Asset_15_4x.png2021-04-08T14:28:55.000Z"85ea6455d7b75410abe200e1178a16cb"10397STANDARDblog_images/images/000/000/015/medium/Asset_19_4x.png2021-04-08T14:29:12.000Z"9efff49885f304726ea4ecb0b869fca5"51830STANDARDblog_images/images/000/000/015/original/Asset_19_4x.png2021-04-08T14:29:12.000Z"4921ce222df9e872608d10abbf8bcb2c"25073STANDARDblog_images/images/000/000/015/small/Asset_19_4x.png2021-04-08T14:29:12.000Z"05ad08d81f1985b1f3d873b841483259"16848STANDARDblog_images/images/000/000/015/thumb/Asset_19_4x.png2021-04-08T14:29:12.000Z"4a4daacbc37151dc671e27f21e3b6fba"12011STANDARDblog_images/images/000/000/016/medium/Asset_11.png2021-06-04T18:31:12.000Z"3688d0b516a30f0f31020d20c97ed6a8"2418STANDARDblog_images/images/000/000/016/original/Asset_11.png2021-06-04T18:31:12.000Z"48a99f793bb01c610d475c0e6256350f"5361STANDARDblog_images/images/000/000/016/small/Asset_11.png2021-06-04T18:31:12.000Z"3688d0b516a30f0f31020d20c97ed6a8"2418STANDARDblog_images/images/000/000/016/thumb/Asset_11.png2021-06-04T18:31:12.000Z"3688d0b516a30f0f31020d20c97ed6a8"2418STANDARDblog_images/images/000/000/017/medium/Asset_9.png2021-06-04T18:31:39.000Z"3c742f442835f0d7e2b2b6bd4e5b8768"1965STANDARDblog_images/images/000/000/017/original/Asset_9.png2021-06-04T18:31:39.000Z"cec6cf84fd158198bb54bcf6843e9569"3687STANDARDblog_images/images/000/000/017/small/Asset_9.png2021-06-04T18:31:39.000Z"3c742f442835f0d7e2b2b6bd4e5b8768"1965STANDARDblog_images/images/000/000/017/thumb/Asset_9.png2021-06-04T18:31:39.000Z"3c742f442835f0d7e2b2b6bd4e5b8768"1965STANDARDblog_images/images/000/000/018/medium/Asset_15_4x.png2021-06-04T18:32:02.000Z"d535eed9aaa23baac58cb7498981606a"39760STANDARDblog_images/images/000/000/018/original/Asset_15_4x.png2021-06-04T18:32:02.000Z"f45ee58fb47f7961c96d08db0c4e079a"19982STANDARDblog_images/images/000/000/018/small/Asset_15_4x.png2021-06-04T18:32:02.000Z"5f50461468b523f2627228d1e03e05d9"14294STANDARDblog_images/images/000/000/018/thumb/Asset_15_4x.png2021-06-04T18:32:02.000Z"4442ab6228f6600e4727037e9710b788"10397STANDARDblog_images/images/000/000/019/medium/Asset_18_4x.png2021-06-04T18:32:17.000Z"fbeb31a6194174e6d7061d22b0e8dcdf"8789STANDARDblog_images/images/000/000/019/original/Asset_18_4x.png2021-06-04T18:32:17.000Z"10c70b65eb5bb318574ce34a6cd2abc7"5884STANDARDblog_images/images/000/000/019/small/Asset_18_4x.png2021-06-04T18:32:17.000Z"d25a6b1e984fe12267ae1fb70f228ace"3834STANDARDblog_images/images/000/000/019/thumb/Asset_18_4x.png2021-06-04T18:32:17.000Z"cb908e1fed6d8043d2a77fb82f2f2dcf"3072STANDARDblog_images/images/000/000/020/medium/Asset_11.png2021-06-10T13:56:44.000Z"d608ab015a0fdc8f7a6cd3f9cbd87e29"2418STANDARDblog_images/images/000/000/020/original/Asset_11.png2021-06-10T13:56:44.000Z"48a99f793bb01c610d475c0e6256350f"5361STANDARDblog_images/images/000/000/020/small/Asset_11.png2021-06-10T13:56:44.000Z"d608ab015a0fdc8f7a6cd3f9cbd87e29"2418STANDARDblog_images/images/000/000/020/thumb/Asset_11.png2021-06-10T13:56:44.000Z"d608ab015a0fdc8f7a6cd3f9cbd87e29"2418STANDARDblog_images/images/000/000/021/medium/Asset_9.png2021-06-10T13:57:23.000Z"1b8125509f50f1f90b9ba101ee0bd297"1965STANDARDblog_images/images/000/000/021/original/Asset_9.png2021-06-10T13:57:23.000Z"cec6cf84fd158198bb54bcf6843e9569"3687STANDARDblog_images/images/000/000/021/small/Asset_9.png2021-06-10T13:57:23.000Z"1b8125509f50f1f90b9ba101ee0bd297"1965STANDARDblog_images/images/000/000/021/thumb/Asset_9.png2021-06-10T13:57:23.000Z"1b8125509f50f1f90b9ba101ee0bd297"1965STANDARDblog_images/images/000/000/022/medium/Asset_14_4x.png2021-06-10T13:58:08.000Z"65c848a784247cf081ca5dd518785f13"25493STANDARDblog_images/images/000/000/022/original/Asset_14_4x.png2021-06-10T13:58:08.000Z"636cee934a46dc1b4d3c654ee0f85463"14612STANDARDblog_images/images/000/000/022/small/Asset_14_4x.png2021-06-10T13:58:08.000Z"13e11ed477d905795e5461e08c3eee78"9879STANDARDblog_images/images/000/000/022/thumb/Asset_14_4x.png2021-06-10T13:58:08.000Z"ccb2ec49a0712286614fadb19165aa0d"7253STANDARDblog_images/images/000/000/023/medium/Asset_28.png2021-06-10T13:58:59.000Z"345ed9cbd6cde3411d114ea57a017221"1663STANDARDblog_images/images/000/000/023/original/Asset_28.png2021-06-10T13:58:59.000Z"f0ba3f963433fa1e40aa338d52d0e1d8"3509STANDARDblog_images/images/000/000/023/small/Asset_28.png2021-06-10T13:58:59.000Z"345ed9cbd6cde3411d114ea57a017221"1663STANDARDblog_images/images/000/000/023/thumb/Asset_28.png2021-06-10T13:58:59.000Z"345ed9cbd6cde3411d114ea57a017221"1663STANDARDblog_images/images/000/000/053/medium/Asset_15_4x.png2021-11-10T19:00:31.000Z"f889471c7fd3a8a66a6ed9bb9e38a4c3"39760STANDARDblog_images/images/000/000/053/original/Asset_15_4x.png2021-11-10T19:00:31.000Z"f45ee58fb47f7961c96d08db0c4e079a"19982STANDARDblog_images/images/000/000/053/small/Asset_15_4x.png2021-11-10T19:00:31.000Z"418702b950feca38a034c4ae9dad22e7"14294STANDARDblog_images/images/000/000/053/thumb/Asset_15_4x.png2021-11-10T19:00:31.000Z"be5d92467b4c38a29eb09caa0fd81a68"10397STANDARDblog_images/images/000/000/054/medium/Asset_11.png2021-11-10T19:01:06.000Z"62c7e0a9d50dfdec693ee74b13a4be36"2418STANDARDblog_images/images/000/000/054/original/Asset_11.png2021-11-10T19:01:06.000Z"48a99f793bb01c610d475c0e6256350f"5361STANDARDblog_images/images/000/000/054/small/Asset_11.png2021-11-10T19:01:06.000Z"62c7e0a9d50dfdec693ee74b13a4be36"2418STANDARDblog_images/images/000/000/054/thumb/Asset_11.png2021-11-10T19:01:06.000Z"62c7e0a9d50dfdec693ee74b13a4be36"2418STANDARDblog_images/images/000/000/055/medium/Asset_10.png2021-11-10T19:01:23.000Z"109be5947405c8cef03ce012424ba61c"2096STANDARDblog_images/images/000/000/055/original/Asset_10.png2021-11-10T19:01:23.000Z"47a96547f9e29fe2214a22efb6749e0f"4767STANDARDblog_images/images/000/000/055/small/Asset_10.png2021-11-10T19:01:23.000Z"109be5947405c8cef03ce012424ba61c"2096STANDARDblog_images/images/000/000/055/thumb/Asset_10.png2021-11-10T19:01:23.000Z"109be5947405c8cef03ce012424ba61c"2096STANDARDblog_images/images/000/000/056/medium/Asset_10.png2021-11-12T21:59:57.000Z"14d132d19478b06c028d01fa2edff675"2096STANDARDblog_images/images/000/000/056/original/Asset_10.png2021-11-12T21:59:57.000Z"47a96547f9e29fe2214a22efb6749e0f"4767STANDARDblog_images/images/000/000/056/small/Asset_10.png2021-11-12T21:59:57.000Z"14d132d19478b06c028d01fa2edff675"2096STANDARDblog_images/images/000/000/056/thumb/Asset_10.png2021-11-12T21:59:57.000Z"14d132d19478b06c028d01fa2edff675"2096STANDARDblog_images/images/000/000/057/medium/Asset_11.png2021-11-12T22:00:07.000Z"ef2bf296f6c8e028fc9bcc85bbf3a4ab"2418STANDARDblog_images/images/000/000/057/original/Asset_11.png2021-11-12T22:00:07.000Z"48a99f793bb01c610d475c0e6256350f"5361STANDARDblog_images/images/000/000/057/small/Asset_11.png2021-11-12T22:00:07.000Z"ef2bf296f6c8e028fc9bcc85bbf3a4ab"2418STANDARDblog_images/images/000/000/057/thumb/Asset_11.png2021-11-12T22:00:07.000Z"ef2bf296f6c8e028fc9bcc85bbf3a4ab"2418STANDARDblog_images/images/000/000/058/medium/Asset_43_4x.png2021-11-12T22:00:27.000Z"d32f14f74a07bd3ce83e5d6d4d914113"28104STANDARDblog_images/images/000/000/058/original/Asset_43_4x.png2021-11-12T22:00:27.000Z"75d89875b4f4c2b9a73b3383f4662d4c"14873STANDARDblog_images/images/000/000/058/small/Asset_43_4x.png2021-11-12T22:00:27.000Z"eb6d0e044d8f66511b21a423aaca4dc1"10455STANDARDblog_images/images/000/000/058/thumb/Asset_43_4x.png2021-11-12T22:00:27.000Z"a3cc825ae0f9fbb93ba27ba138c4efd3"7670STANDARDblog_images/images/000/000/059/medium/Asset_9.png2021-11-19T19:48:39.000Z"3fd1dd76f75e02cfb4d92966d89b6ea0"1965STANDARDblog_images/images/000/000/059/original/Asset_9.png2021-11-19T19:48:39.000Z"cec6cf84fd158198bb54bcf6843e9569"3687STANDARDblog_images/images/000/000/059/small/Asset_9.png2021-11-19T19:48:39.000Z"3fd1dd76f75e02cfb4d92966d89b6ea0"1965STANDARDblog_images/images/000/000/059/thumb/Asset_9.png2021-11-19T19:48:39.000Z"3fd1dd76f75e02cfb4d92966d89b6ea0"1965STANDARDblog_images/images/000/000/060/medium/Asset_11.png2021-11-19T19:51:36.000Z"e094f35e8e7a844e323b7ce6893b2037"2418STANDARDblog_images/images/000/000/060/original/Asset_11.png2021-11-19T19:51:36.000Z"48a99f793bb01c610d475c0e6256350f"5361STANDARDblog_images/images/000/000/060/small/Asset_11.png2021-11-19T19:51:36.000Z"e094f35e8e7a844e323b7ce6893b2037"2418STANDARDblog_images/images/000/000/060/thumb/Asset_11.png2021-11-19T19:51:36.000Z"e094f35e8e7a844e323b7ce6893b2037"2418STANDARDblog_images/images/000/000/061/medium/Asset_15_4x.png2021-11-19T19:52:25.000Z"dbbf4033870b84dcf8ba2ac16ac70d12"39760STANDARDblog_images/images/000/000/061/original/Asset_15_4x.png2021-11-19T19:52:25.000Z"f45ee58fb47f7961c96d08db0c4e079a"19982STANDARDblog_images/images/000/000/061/small/Asset_15_4x.png2021-11-19T19:52:25.000Z"b2913bc6afa299a81d36c580a99dfae2"14294STANDARDblog_images/images/000/000/061/thumb/Asset_15_4x.png2021-11-19T19:52:25.000Z"7e35c65358358f689858a50b55f1af11"10397STANDARDblog_images/images/000/000/062/medium/inphd_img1.png2022-06-21T18:05:19.000Z"79edd3b303866feb7ae36c93f96f262a"2137STANDARDblog_images/images/000/000/062/original/inphd_img1.png2022-06-21T18:05:19.000Z"253e355dfeb5e04a24e6aeddf027bb2a"2032STANDARDblog_images/images/000/000/062/small/inphd_img1.png2022-06-21T18:05:19.000Z"79edd3b303866feb7ae36c93f96f262a"2137STANDARDblog_images/images/000/000/062/thumb/inphd_img1.png2022-06-21T18:05:19.000Z"79edd3b303866feb7ae36c93f96f262a"2137STANDARDblog_images/images/000/000/063/medium/inphd_img2.png2022-06-21T18:05:29.000Z"119780532ade0268e7f672886708de8d"33428STANDARDblog_images/images/000/000/063/original/inphd_img2.png2022-06-21T18:05:28.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/063/small/inphd_img2.png2022-06-21T18:05:28.000Z"fa4cb15e4693fadef8b8bc527e7ce2ca"11503STANDARDblog_images/images/000/000/063/thumb/inphd_img2.png2022-06-21T18:05:28.000Z"69b9322acf5de2cee093c22416d91b7a"8697STANDARDblog_images/images/000/000/064/medium/inphd_img3.png2022-06-21T18:05:37.000Z"87afae54db861a1633e7758a284df5b1"20751STANDARDblog_images/images/000/000/064/original/inphd_img3.png2022-06-21T18:05:37.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARDblog_images/images/000/000/064/small/inphd_img3.png2022-06-21T18:05:37.000Z"bbd33f90932340edad629d5d8e1a60a2"7964STANDARDblog_images/images/000/000/064/thumb/inphd_img3.png2022-06-21T18:05:37.000Z"d3d1423798c24bba72e888811365af8e"6031STANDARDblog_images/images/000/000/065/medium/inphd_img1.png2022-06-29T20:51:51.000Z"5bc69d99c638024300fdc2d7c8faad64"2137STANDARDblog_images/images/000/000/065/original/inphd_img1.png2022-06-29T20:51:51.000Z"253e355dfeb5e04a24e6aeddf027bb2a"2032STANDARDblog_images/images/000/000/065/small/inphd_img1.png2022-06-29T20:51:51.000Z"5bc69d99c638024300fdc2d7c8faad64"2137STANDARDblog_images/images/000/000/065/thumb/inphd_img1.png2022-06-29T20:51:51.000Z"5bc69d99c638024300fdc2d7c8faad64"2137STANDARDblog_images/images/000/000/066/medium/inphd_img2.png2022-06-29T20:52:02.000Z"f6d9104a1421bc846b316ad482852818"33428STANDARDblog_images/images/000/000/066/original/inphd_img2.png2022-06-29T20:52:01.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/066/small/inphd_img2.png2022-06-29T20:52:01.000Z"110c26024f2e44c63e2ad47858071454"11503STANDARDblog_images/images/000/000/066/thumb/inphd_img2.png2022-06-29T20:52:01.000Z"9ba4fce1e91e6dc0f5ce6b87e747ac12"8697STANDARDblog_images/images/000/000/067/medium/inphd_img3.png2022-06-29T20:52:12.000Z"073c6b53bde91eb6b486f396a481e72e"20751STANDARDblog_images/images/000/000/067/original/inphd_img3.png2022-06-29T20:52:12.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARDblog_images/images/000/000/067/small/inphd_img3.png2022-06-29T20:52:12.000Z"410c34d5d9a7138e8f0eccae5f1485f7"7964STANDARDblog_images/images/000/000/067/thumb/inphd_img3.png2022-06-29T20:52:12.000Z"401fa33ae17313a0832563c997c5aafc"6031STANDARDblog_images/images/000/000/068/medium/InpharmDpic1.png2022-07-05T21:40:25.000Z"009b6d55b5e0210bdd2a4b41c49e4be5"2137STANDARDblog_images/images/000/000/068/original/InpharmDpic1.png2022-07-05T21:40:25.000Z"253e355dfeb5e04a24e6aeddf027bb2a"2032STANDARDblog_images/images/000/000/068/small/InpharmDpic1.png2022-07-05T21:40:25.000Z"009b6d55b5e0210bdd2a4b41c49e4be5"2137STANDARDblog_images/images/000/000/068/thumb/InpharmDpic1.png2022-07-05T21:40:25.000Z"009b6d55b5e0210bdd2a4b41c49e4be5"2137STANDARDblog_images/images/000/000/069/medium/Inpharmdpic2.png2022-07-05T21:41:10.000Z"fb3a5919d56db2f300884dfe0324ed9a"33428STANDARDblog_images/images/000/000/069/original/Inpharmdpic2.png2022-07-05T21:41:10.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/069/small/Inpharmdpic2.png2022-07-05T21:41:10.000Z"44498f232a6f3285f742444b54ad8400"11503STANDARDblog_images/images/000/000/069/thumb/Inpharmdpic2.png2022-07-05T21:41:10.000Z"d9bf98a9e05dce651e7934867cbc659a"8697STANDARDblog_images/images/000/000/070/medium/Inpharmdpic3.png2022-07-05T21:41:25.000Z"8e0a3fa1b4a128c4f6efab15ad66ae8c"20751STANDARDblog_images/images/000/000/070/original/Inpharmdpic3.png2022-07-05T21:41:24.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARDblog_images/images/000/000/070/small/Inpharmdpic3.png2022-07-05T21:41:25.000Z"9ff8cf3e30c912f7f0d44bf3215eb832"7964STANDARDblog_images/images/000/000/070/thumb/Inpharmdpic3.png2022-07-05T21:41:25.000Z"548b2fae5bb0c582982571fb1da083cb"6031STANDARDblog_images/images/000/000/071/medium/Inpharmdpic2.png2022-07-07T16:46:07.000Z"188a9026648f1ec6c206c76851b35911"33428STANDARDblog_images/images/000/000/071/original/Inpharmdpic2.png2022-07-07T16:46:07.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/071/small/Inpharmdpic2.png2022-07-07T16:46:07.000Z"550f6adafba283277da2e04224f721bc"11503STANDARDblog_images/images/000/000/071/thumb/Inpharmdpic2.png2022-07-07T16:46:07.000Z"434104d3c1130055ac03ce4b8c55559a"8697STANDARDblog_images/images/000/000/072/medium/Inpharmdpic3.png2022-07-07T16:46:22.000Z"72ecb6a06de7580ba68cacdf66767859"20751STANDARDblog_images/images/000/000/072/original/Inpharmdpic3.png2022-07-07T16:46:21.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARDblog_images/images/000/000/072/small/Inpharmdpic3.png2022-07-07T16:46:22.000Z"bf70eaaa79f2654162e79524980a4676"7964STANDARDblog_images/images/000/000/072/thumb/Inpharmdpic3.png2022-07-07T16:46:22.000Z"173e163f72e60d14c98256a6e4f986a0"6031STANDARDblog_images/images/000/000/073/medium/InpharmDpic1.png2022-07-15T03:48:18.000Z"c4e05c6445552a8b982162185efd1caa"2137STANDARDblog_images/images/000/000/073/original/InpharmDpic1.png2022-07-15T03:48:18.000Z"253e355dfeb5e04a24e6aeddf027bb2a"2032STANDARDblog_images/images/000/000/073/small/InpharmDpic1.png2022-07-15T03:48:18.000Z"c4e05c6445552a8b982162185efd1caa"2137STANDARDblog_images/images/000/000/073/thumb/InpharmDpic1.png2022-07-15T03:48:18.000Z"c4e05c6445552a8b982162185efd1caa"2137STANDARDblog_images/images/000/000/074/medium/Inpharmdpic2.png2022-07-15T03:48:35.000Z"d0e6d6437a42f0dabb996e84f0f397da"33428STANDARDblog_images/images/000/000/074/original/Inpharmdpic2.png2022-07-15T03:48:35.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/074/small/Inpharmdpic2.png2022-07-15T03:48:35.000Z"150c0473470669635c8c3363719082c1"11503STANDARDblog_images/images/000/000/074/thumb/Inpharmdpic2.png2022-07-15T03:48:35.000Z"d8636498f8bc6cb7b186c37e89dc8744"8697STANDARDblog_images/images/000/000/075/medium/Inpharmdpic3.png2022-07-15T03:48:48.000Z"b42cd0d9b42170bd04c1755240d0c9f2"20751STANDARDblog_images/images/000/000/075/original/Inpharmdpic3.png2022-07-15T03:48:48.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARDblog_images/images/000/000/075/small/Inpharmdpic3.png2022-07-15T03:48:48.000Z"9b1b6f942686ee66a40700c1b0e4e3e6"7964STANDARDblog_images/images/000/000/075/thumb/Inpharmdpic3.png2022-07-15T03:48:48.000Z"4e6a3089f3fc9c3d63e76e96fb3aa6ce"6031STANDARDblog_images/images/000/000/076/medium/InpharmDpic1.png2022-08-04T23:26:13.000Z"86a7b0202b4eb2b89d894a1012040e71"2137STANDARDblog_images/images/000/000/076/original/InpharmDpic1.png2022-08-04T23:26:13.000Z"253e355dfeb5e04a24e6aeddf027bb2a"2032STANDARDblog_images/images/000/000/076/small/InpharmDpic1.png2022-08-04T23:26:13.000Z"86a7b0202b4eb2b89d894a1012040e71"2137STANDARDblog_images/images/000/000/076/thumb/InpharmDpic1.png2022-08-04T23:26:13.000Z"86a7b0202b4eb2b89d894a1012040e71"2137STANDARDblog_images/images/000/000/077/medium/Inpharmdpic2.png2022-08-04T23:26:41.000Z"0c0c20e095c914a263841f3abddb8539"33428STANDARDblog_images/images/000/000/077/original/Inpharmdpic2.png2022-08-04T23:26:40.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/077/small/Inpharmdpic2.png2022-08-04T23:26:41.000Z"f89173ded2d7319f8e0bbbd3046369c9"11503STANDARDblog_images/images/000/000/077/thumb/Inpharmdpic2.png2022-08-04T23:26:41.000Z"7122968aa7a0e299ece2153af87ad99e"8697STANDARDblog_images/images/000/000/078/medium/Inpharmdpic3.png2022-08-04T23:26:51.000Z"529e21e5b27a51c1a9eacd68d46700c3"20751STANDARDblog_images/images/000/000/078/original/Inpharmdpic3.png2022-08-04T23:26:51.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARDblog_images/images/000/000/078/small/Inpharmdpic3.png2022-08-04T23:26:51.000Z"18fa2b5a7fe2052ee00a70ff07d8f31e"7964STANDARDblog_images/images/000/000/078/thumb/Inpharmdpic3.png2022-08-04T23:26:51.000Z"3fba23a8c9ad1d5ca31d34fcc42aacf3"6031STANDARDblog_images/images/000/000/079/medium/InpharmDpic1.png2022-08-19T03:43:05.000Z"12f25a5ede2f214fffbcfa910b28fd06"2137STANDARDblog_images/images/000/000/079/original/InpharmDpic1.png2022-08-19T03:43:05.000Z"253e355dfeb5e04a24e6aeddf027bb2a"2032STANDARDblog_images/images/000/000/079/small/InpharmDpic1.png2022-08-19T03:43:05.000Z"12f25a5ede2f214fffbcfa910b28fd06"2137STANDARDblog_images/images/000/000/079/thumb/InpharmDpic1.png2022-08-19T03:43:05.000Z"12f25a5ede2f214fffbcfa910b28fd06"2137STANDARDblog_images/images/000/000/080/medium/Inpharmdpic2.png2022-08-19T03:43:19.000Z"5a51a8e59ecbf00240e9b32f4c884233"33428STANDARDblog_images/images/000/000/080/original/Inpharmdpic2.png2022-08-19T03:43:19.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/080/small/Inpharmdpic2.png2022-08-19T03:43:19.000Z"aad22ab23cd380a8ed19b2a493c16b14"11503STANDARDblog_images/images/000/000/080/thumb/Inpharmdpic2.png2022-08-19T03:43:19.000Z"d779f18a4d48db3d5ab0f4342636d02b"8697STANDARDblog_images/images/000/000/081/medium/Inpharmdpic3.png2022-08-19T03:43:31.000Z"5b95f6b83c40a6c0051cf6971f8f0d05"20751STANDARDblog_images/images/000/000/081/original/Inpharmdpic3.png2022-08-19T03:43:31.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARDblog_images/images/000/000/081/small/Inpharmdpic3.png2022-08-19T03:43:31.000Z"95bee9ee9e7c6303a80da2e0ec36ccef"7964STANDARDblog_images/images/000/000/081/thumb/Inpharmdpic3.png2022-08-19T03:43:31.000Z"1884337a68fcc028cff621cc37a70c73"6031STANDARDblog_images/images/000/000/082/medium/InpharmDpic1.png2022-08-26T14:29:53.000Z"039776d7046279704cf70ecc02c8298d"2137STANDARDblog_images/images/000/000/082/original/InpharmDpic1.png2022-08-26T14:29:52.000Z"253e355dfeb5e04a24e6aeddf027bb2a"2032STANDARDblog_images/images/000/000/082/small/InpharmDpic1.png2022-08-26T14:29:53.000Z"039776d7046279704cf70ecc02c8298d"2137STANDARDblog_images/images/000/000/082/thumb/InpharmDpic1.png2022-08-26T14:29:53.000Z"039776d7046279704cf70ecc02c8298d"2137STANDARDblog_images/images/000/000/083/medium/Inpharmdpic2.png2022-08-26T14:30:15.000Z"be3823c96adc451fa3896aa6c8ec4fd8"33428STANDARDblog_images/images/000/000/083/original/Inpharmdpic2.png2022-08-26T14:30:15.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/083/small/Inpharmdpic2.png2022-08-26T14:30:15.000Z"04fb541a034a7fcfa4eb6ead0fced4fc"11503STANDARDblog_images/images/000/000/083/thumb/Inpharmdpic2.png2022-08-26T14:30:15.000Z"f5ac0d1f68f075468d1fa8991cc8f1c0"8697STANDARDblog_images/images/000/000/084/medium/Inpharmdpic3.png2022-08-26T14:30:29.000Z"56fd8328c23f6ffa5878cb544a4ac600"20751STANDARDblog_images/images/000/000/084/original/Inpharmdpic3.png2022-08-26T14:30:29.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARDblog_images/images/000/000/084/small/Inpharmdpic3.png2022-08-26T14:30:29.000Z"c40e20aa8540d3ad1ba8b7e9d40aa019"7964STANDARDblog_images/images/000/000/084/thumb/Inpharmdpic3.png2022-08-26T14:30:29.000Z"819d1c672acf252ddf16cb87f7dd257a"6031STANDARDblog_images/images/000/000/085/medium/InpharmDpic1.png2022-09-16T23:04:29.000Z"a0ab3e01f643031dbc343ab648acdb08"2137STANDARDblog_images/images/000/000/085/original/InpharmDpic1.png2022-09-16T23:04:29.000Z"253e355dfeb5e04a24e6aeddf027bb2a"2032STANDARDblog_images/images/000/000/085/small/InpharmDpic1.png2022-09-16T23:04:29.000Z"a0ab3e01f643031dbc343ab648acdb08"2137STANDARDblog_images/images/000/000/085/thumb/InpharmDpic1.png2022-09-16T23:04:29.000Z"a0ab3e01f643031dbc343ab648acdb08"2137STANDARDblog_images/images/000/000/086/medium/Inpharmdpic2.png2022-09-16T23:04:56.000Z"05278022fcdeff6e168aa729660678e8"33428STANDARDblog_images/images/000/000/086/original/Inpharmdpic2.png2022-09-16T23:04:56.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/086/small/Inpharmdpic2.png2022-09-16T23:04:56.000Z"ed1125d71355fb0dabc35505c4be754c"11503STANDARDblog_images/images/000/000/086/thumb/Inpharmdpic2.png2022-09-16T23:04:56.000Z"0506f474fdc625600b23cc227fd8f78a"8697STANDARDblog_images/images/000/000/087/medium/Inpharmdpic3.png2022-09-16T23:05:09.000Z"516ee58bb419588c95d04f2552d45470"20751STANDARDblog_images/images/000/000/087/original/Inpharmdpic3.png2022-09-16T23:05:09.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARDblog_images/images/000/000/087/small/Inpharmdpic3.png2022-09-16T23:05:09.000Z"a6b50011f98c20b68ce16cd52fe884bb"7964STANDARDblog_images/images/000/000/087/thumb/Inpharmdpic3.png2022-09-16T23:05:09.000Z"ead9f73754cdece20e664d46737f6a20"6031STANDARDblog_images/images/000/000/088/medium/InpharmDpic1.png2022-09-23T02:39:37.000Z"84efbcbd213b07b8f8468def3918d3e6"2137STANDARDblog_images/images/000/000/088/original/InpharmDpic1.png2022-09-23T02:39:37.000Z"253e355dfeb5e04a24e6aeddf027bb2a"2032STANDARDblog_images/images/000/000/088/small/InpharmDpic1.png2022-09-23T02:39:37.000Z"84efbcbd213b07b8f8468def3918d3e6"2137STANDARDblog_images/images/000/000/088/thumb/InpharmDpic1.png2022-09-23T02:39:37.000Z"84efbcbd213b07b8f8468def3918d3e6"2137STANDARDblog_images/images/000/000/089/medium/Inpharmdpic2.png2022-09-23T02:39:53.000Z"d5f62ebf17d38614f92281b54c4a1143"33428STANDARDblog_images/images/000/000/089/original/Inpharmdpic2.png2022-09-23T02:39:53.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/089/small/Inpharmdpic2.png2022-09-23T02:39:53.000Z"16bbf2c70f4481c991a639c9406b85c6"11503STANDARDblog_images/images/000/000/089/thumb/Inpharmdpic2.png2022-09-23T02:39:53.000Z"ad1c5104ce1db80f66c45742f48fddba"8697STANDARDblog_images/images/000/000/090/medium/Inpharmdpic3.png2022-09-23T02:40:07.000Z"0f69f56684c4e25b6b02e16015fc7776"20751STANDARDblog_images/images/000/000/090/original/Inpharmdpic3.png2022-09-23T02:40:07.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARDblog_images/images/000/000/090/small/Inpharmdpic3.png2022-09-23T02:40:07.000Z"721185c8b89532a2c0676802cadce6d8"7964STANDARDblog_images/images/000/000/090/thumb/Inpharmdpic3.png2022-09-23T02:40:07.000Z"9649f7cacfabe2638ca5342968c57b07"6031STANDARDblog_images/images/000/000/091/medium/InpharmDpic1.png2022-09-30T03:32:17.000Z"c588ba22446934e795b60f78b7f62b39"2137STANDARDblog_images/images/000/000/091/original/InpharmDpic1.png2022-09-30T03:32:16.000Z"253e355dfeb5e04a24e6aeddf027bb2a"2032STANDARDblog_images/images/000/000/091/small/InpharmDpic1.png2022-09-30T03:32:16.000Z"c588ba22446934e795b60f78b7f62b39"2137STANDARDblog_images/images/000/000/091/thumb/InpharmDpic1.png2022-09-30T03:32:16.000Z"c588ba22446934e795b60f78b7f62b39"2137STANDARDblog_images/images/000/000/092/medium/Inpharmdpic2.png2022-09-30T03:32:27.000Z"09f9c202060f36b1ffe2bb908dedcaa5"33428STANDARDblog_images/images/000/000/092/original/Inpharmdpic2.png2022-09-30T03:32:27.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/092/small/Inpharmdpic2.png2022-09-30T03:32:27.000Z"223739d25e766117ac169b7ffbb57dde"11503STANDARDblog_images/images/000/000/092/thumb/Inpharmdpic2.png2022-09-30T03:32:27.000Z"89a24cef84b74af0ada7f2bbc2a9b19a"8697STANDARDblog_images/images/000/000/093/medium/Inpharmdpic3.png2022-09-30T03:32:38.000Z"cc59ed0eeff12378035a6c948a72f8ea"20751STANDARDblog_images/images/000/000/093/original/Inpharmdpic3.png2022-09-30T03:32:37.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARDblog_images/images/000/000/093/small/Inpharmdpic3.png2022-09-30T03:32:37.000Z"78d60f512f8200eb2b33b9aad64fcf3b"7964STANDARDblog_images/images/000/000/093/thumb/Inpharmdpic3.png2022-09-30T03:32:37.000Z"05075801c18ecb57326a1b3dd24decee"6031STANDARDblog_images/images/000/000/094/medium/InpharmDpic1.png2022-10-07T23:29:28.000Z"784f57079c233f1d274cb5575525f0fe"2137STANDARDblog_images/images/000/000/094/original/InpharmDpic1.png2022-10-07T23:29:28.000Z"253e355dfeb5e04a24e6aeddf027bb2a"2032STANDARDblog_images/images/000/000/094/small/InpharmDpic1.png2022-10-07T23:29:28.000Z"784f57079c233f1d274cb5575525f0fe"2137STANDARDblog_images/images/000/000/094/thumb/InpharmDpic1.png2022-10-07T23:29:28.000Z"784f57079c233f1d274cb5575525f0fe"2137STANDARDblog_images/images/000/000/095/medium/Inpharmdpic2.png2022-10-07T23:29:39.000Z"c6da3aab7bc4350e7a9b40d87184a080"33428STANDARDblog_images/images/000/000/095/original/Inpharmdpic2.png2022-10-07T23:29:39.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/095/small/Inpharmdpic2.png2022-10-07T23:29:39.000Z"6000c147f11d5b10f3cd096b35277841"11503STANDARDblog_images/images/000/000/095/thumb/Inpharmdpic2.png2022-10-07T23:29:39.000Z"f21c5d2b35545c2a6f7200406cac5282"8697STANDARDblog_images/images/000/000/096/medium/Inpharmdpic3.png2022-10-07T23:29:55.000Z"360c4c7e2f6b5f416f7310dafbb8c503"20751STANDARDblog_images/images/000/000/096/original/Inpharmdpic3.png2022-10-07T23:29:55.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARDblog_images/images/000/000/096/small/Inpharmdpic3.png2022-10-07T23:29:55.000Z"54d3e6d95dac7dbc50d1cc6689327a91"7964STANDARDblog_images/images/000/000/096/thumb/Inpharmdpic3.png2022-10-07T23:29:55.000Z"7918eed9a090f4eae80fb82e124f551f"6031STANDARDblog_images/images/000/000/097/medium/InpharmDpic1.png2022-10-14T01:20:42.000Z"d13ee147249c3d4cb95df9eac9d46a12"2137STANDARDblog_images/images/000/000/097/original/InpharmDpic1.png2022-10-14T01:20:42.000Z"253e355dfeb5e04a24e6aeddf027bb2a"2032STANDARDblog_images/images/000/000/097/small/InpharmDpic1.png2022-10-14T01:20:42.000Z"d13ee147249c3d4cb95df9eac9d46a12"2137STANDARDblog_images/images/000/000/097/thumb/InpharmDpic1.png2022-10-14T01:20:42.000Z"d13ee147249c3d4cb95df9eac9d46a12"2137STANDARDblog_images/images/000/000/098/medium/Inpharmdpic2.png2022-10-14T01:21:01.000Z"dc98288aa4893a64d74fa796788cdd75"33428STANDARDblog_images/images/000/000/098/original/Inpharmdpic2.png2022-10-14T01:21:01.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/098/small/Inpharmdpic2.png2022-10-14T01:21:01.000Z"cc8e4d780e8965b836270d582ba92ea2"11503STANDARDblog_images/images/000/000/098/thumb/Inpharmdpic2.png2022-10-14T01:21:01.000Z"c54a50cc8ef24443cc985eee1c61c705"8697STANDARDblog_images/images/000/000/099/medium/Inpharmdpic3.png2022-10-14T01:21:13.000Z"6f820805bbe78a68cfdfb4db7fa8ffd1"20751STANDARDblog_images/images/000/000/099/original/Inpharmdpic3.png2022-10-14T01:21:13.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARDblog_images/images/000/000/099/small/Inpharmdpic3.png2022-10-14T01:21:13.000Z"968ac9293347ce46e33b4dbe5b77a59b"7964STANDARDblog_images/images/000/000/099/thumb/Inpharmdpic3.png2022-10-14T01:21:13.000Z"ef1f08623ad949a1d93d76e3d14d8a29"6031STANDARDblog_images/images/000/000/100/medium/InpharmDpic1.png2022-10-21T03:18:12.000Z"0ceaa0f14aeaf796d2eb6a17314a6b6e"2137STANDARDblog_images/images/000/000/100/original/InpharmDpic1.png2022-10-21T03:18:11.000Z"253e355dfeb5e04a24e6aeddf027bb2a"2032STANDARDblog_images/images/000/000/100/small/InpharmDpic1.png2022-10-21T03:18:12.000Z"0ceaa0f14aeaf796d2eb6a17314a6b6e"2137STANDARDblog_images/images/000/000/100/thumb/InpharmDpic1.png2022-10-21T03:18:11.000Z"0ceaa0f14aeaf796d2eb6a17314a6b6e"2137STANDARDblog_images/images/000/000/101/medium/Inpharmdpic2.png2022-10-21T03:18:23.000Z"02b444b0241b2f8a7fa4de0938fdc361"33428STANDARDblog_images/images/000/000/101/original/Inpharmdpic2.png2022-10-21T03:18:23.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/101/small/Inpharmdpic2.png2022-10-21T03:18:23.000Z"fa41057484916148c60c53d4a1d40609"11503STANDARDblog_images/images/000/000/101/thumb/Inpharmdpic2.png2022-10-21T03:18:23.000Z"48309327797e5bbc5f36a481546d8b28"8697STANDARDblog_images/images/000/000/102/medium/Inpharmdpic3.png2022-10-21T03:18:39.000Z"6755b917195fcc2a87e23e87435d5d1f"20751STANDARDblog_images/images/000/000/102/original/Inpharmdpic3.png2022-10-21T03:18:39.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARDblog_images/images/000/000/102/small/Inpharmdpic3.png2022-10-21T03:18:39.000Z"7fc30eb1bed8532db2dc945fd61797a2"7964STANDARDblog_images/images/000/000/102/thumb/Inpharmdpic3.png2022-10-21T03:18:39.000Z"2b64f94708038d39ccb38f39574cdfcf"6031STANDARDblog_images/images/000/000/103/medium/InpharmDpic1.png2022-10-28T02:32:26.000Z"18ab85179c10ecd22c1a8b4107671148"2137STANDARDblog_images/images/000/000/103/original/InpharmDpic1.png2022-10-28T02:32:26.000Z"253e355dfeb5e04a24e6aeddf027bb2a"2032STANDARDblog_images/images/000/000/103/small/InpharmDpic1.png2022-10-28T02:32:26.000Z"18ab85179c10ecd22c1a8b4107671148"2137STANDARDblog_images/images/000/000/103/thumb/InpharmDpic1.png2022-10-28T02:32:26.000Z"18ab85179c10ecd22c1a8b4107671148"2137STANDARDblog_images/images/000/000/104/medium/Inpharmdpic2.png2022-10-28T02:32:55.000Z"0409442f9afd7f4e5b70e08f69a45660"33428STANDARDblog_images/images/000/000/104/original/Inpharmdpic2.png2022-10-28T02:32:55.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/104/small/Inpharmdpic2.png2022-10-28T02:32:55.000Z"fe1c7cd5281ed30c92ff5d55708ceaee"11503STANDARDblog_images/images/000/000/104/thumb/Inpharmdpic2.png2022-10-28T02:32:55.000Z"6eca2b0609b3f6137f5c591c555bd5e2"8697STANDARDblog_images/images/000/000/105/medium/Inpharmdpic3.png2022-10-28T02:33:12.000Z"ffb481cd8990cae9d673abd680ef6a19"20751STANDARDblog_images/images/000/000/105/original/Inpharmdpic3.png2022-10-28T02:33:11.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARDblog_images/images/000/000/105/small/Inpharmdpic3.png2022-10-28T02:33:11.000Z"91aa4b28b40cfc811c7f21eb476d113c"7964STANDARDblog_images/images/000/000/105/thumb/Inpharmdpic3.png2022-10-28T02:33:11.000Z"b42eb2d099884fe82f16060bc23c0c1f"6031STANDARDblog_images/images/000/000/106/medium/InpharmDpic1.png2022-11-03T18:12:43.000Z"4ea4faf18637b3fdb5911471256c725d"2137STANDARDblog_images/images/000/000/106/original/InpharmDpic1.png2022-11-03T18:12:42.000Z"253e355dfeb5e04a24e6aeddf027bb2a"2032STANDARDblog_images/images/000/000/106/small/InpharmDpic1.png2022-11-03T18:12:43.000Z"4ea4faf18637b3fdb5911471256c725d"2137STANDARDblog_images/images/000/000/106/thumb/InpharmDpic1.png2022-11-03T18:12:43.000Z"4ea4faf18637b3fdb5911471256c725d"2137STANDARDblog_images/images/000/000/107/medium/Inpharmdpic2.png2022-11-03T18:12:56.000Z"53504cde765b6486a1d61f6bdbee315e"33428STANDARDblog_images/images/000/000/107/original/Inpharmdpic2.png2022-11-03T18:12:56.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/107/small/Inpharmdpic2.png2022-11-03T18:12:56.000Z"faa1239727ada38b1acb6d1fb1bc7457"11503STANDARDblog_images/images/000/000/107/thumb/Inpharmdpic2.png2022-11-03T18:12:56.000Z"5b31243f38efa1d93fe1fa90e0a48b1a"8697STANDARDblog_images/images/000/000/108/medium/Inpharmdpic3.png2022-11-03T18:13:09.000Z"680f36b21060e92faf4325297dcec077"20751STANDARDblog_images/images/000/000/108/original/Inpharmdpic3.png2022-11-03T18:13:09.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARDblog_images/images/000/000/108/small/Inpharmdpic3.png2022-11-03T18:13:09.000Z"1cd908e4c392e47cd692bec9f76b60ee"7964STANDARDblog_images/images/000/000/108/thumb/Inpharmdpic3.png2022-11-03T18:13:09.000Z"7962acb0d3e17ee95978edfbe96aa531"6031STANDARDblog_images/images/000/000/109/medium/InpharmDpic1.png2022-11-11T17:19:28.000Z"6233095c5411e0942e4de94b00b9cda1"2137STANDARDblog_images/images/000/000/109/original/InpharmDpic1.png2022-11-11T17:19:28.000Z"253e355dfeb5e04a24e6aeddf027bb2a"2032STANDARDblog_images/images/000/000/109/small/InpharmDpic1.png2022-11-11T17:19:28.000Z"6233095c5411e0942e4de94b00b9cda1"2137STANDARDblog_images/images/000/000/109/thumb/InpharmDpic1.png2022-11-11T17:19:28.000Z"6233095c5411e0942e4de94b00b9cda1"2137STANDARDblog_images/images/000/000/110/medium/Inpharmdpic2.png2022-11-11T17:19:39.000Z"ca644d7578b7aa7abf9c0e6dd56d028a"33428STANDARDblog_images/images/000/000/110/original/Inpharmdpic2.png2022-11-11T17:19:39.000Z"5653ea0332898d9513fcea778c4a06e5"9199STANDARDblog_images/images/000/000/110/small/Inpharmdpic2.png2022-11-11T17:19:39.000Z"6def64ba722e9c32b21272b3af8f48fc"11503STANDARDblog_images/images/000/000/110/thumb/Inpharmdpic2.png2022-11-11T17:19:39.000Z"7734e4a57856c89045ce11a63cf09db7"8697STANDARDblog_images/images/000/000/111/medium/Inpharmdpic3.png2022-11-11T17:19:50.000Z"dee81cd54db8218be1f42d53811dd410"20751STANDARDblog_images/images/000/000/111/original/Inpharmdpic3.png2022-11-11T17:19:50.000Z"6f45bf8956b981a184b6535b40016a63"5623STANDARD